<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004128.pub4" GROUP_ID="ANAESTH" ID="943403012517295536" MERGED_FROM="" MODIFIED="2016-02-15 11:04:00 +0000" MODIFIED_BY="Jane Cracknell" REVIEW_NO="064" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.2">
<COVER_SHEET MODIFIED="2016-02-15 11:04:00 +0000" MODIFIED_BY="Jane Cracknell">
<TITLE MODIFIED="2015-04-15 08:16:18 +0100" MODIFIED_BY="Jasmin ">Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation</TITLE>
<CONTACT MODIFIED="2016-02-15 11:04:00 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="2E3188E882E26AA2010AB3F26DD77741" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jasmin</FIRST_NAME><LAST_NAME>Arrich</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>jasmin.arrich@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20 / 6D</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+ 43 1 40400 1964</PHONE_1><FAX_1>+ 43 1 40400 1965</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2016-02-15 11:04:00 +0000" MODIFIED_BY="Jane Cracknell"><PERSON ID="2E3188E882E26AA2010AB3F26DD77741" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Jasmin</FIRST_NAME><LAST_NAME>Arrich</LAST_NAME><POSITION>Associate Professor</POSITION><EMAIL_1>jasmin.arrich@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20 / 6D</ADDRESS_1><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+ 43 1 40400 1964</PHONE_1><FAX_1>+ 43 1 40400 1965</FAX_1></ADDRESS></PERSON><PERSON ID="12595" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Michael</FIRST_NAME><LAST_NAME>Holzer</LAST_NAME><EMAIL_1>michael.holzer@meduniwien.ac.at</EMAIL_1><MOBILE_PHONE>+43 664 2632869</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger</ADDRESS_1><ADDRESS_2>Gürtel 18-20/6D</ADDRESS_2><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 140400 ext 1964</PHONE_1><FAX_1>+43 1 40400 1965</FAX_1></ADDRESS></PERSON><PERSON ID="12591" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christof</FIRST_NAME><LAST_NAME>Havel</LAST_NAME><EMAIL_1>christof.havel@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Währinger Gürtel 18-20 / 6D</ADDRESS_1><CITY>Vienna</CITY><ZIP>A-1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 1 40400 ext: 1964</PHONE_1><FAX_1>+43 1 40400 1965</FAX_1></ADDRESS></PERSON><PERSON ID="11794" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Marcus</FIRST_NAME><LAST_NAME>Müllner</LAST_NAME><SUFFIX>MD MSc</SUFFIX><POSITION>Consultant Physician</POSITION><EMAIL_1>marcusmuellner@yahoo.com</EMAIL_1><ADDRESS><ORGANISATION>Internistisches Zentrum Brigittenau</ORGANISATION><ADDRESS_1>Treustrasse 43</ADDRESS_1><CITY>Vienna</CITY><ZIP>1200</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+43 6603759450</PHONE_1></ADDRESS></PERSON><PERSON ID="12150" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Harald</FIRST_NAME><LAST_NAME>Herkner</LAST_NAME><SUFFIX>MSc</SUFFIX><POSITION>Assoc. Prof. Emergency Medicine</POSITION><EMAIL_1>harald.herkner@meduniwien.ac.at</EMAIL_1><ADDRESS><DEPARTMENT>Department of Emergency Medicine</DEPARTMENT><ORGANISATION>Medical University of Vienna</ORGANISATION><ADDRESS_1>Vienna General Hospital;</ADDRESS_1><ADDRESS_2>Währinger Gürtel 18-20 / 6D</ADDRESS_2><CITY>Vienna</CITY><ZIP>1090</ZIP><COUNTRY CODE="AT">Austria</COUNTRY><PHONE_1>+ 431404001964</PHONE_1><PHONE_2>+ 436764071311</PHONE_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2016-02-15 10:49:08 +0000" MODIFIED_BY="Jane Cracknell">
<UP_TO_DATE>
<DATE DAY="7" MONTH="5" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="7" MONTH="5" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="1" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2009"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-02-15 10:50:21 +0000" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-15 10:50:16 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="15" MONTH="2" YEAR="2016"/>
<DESCRIPTION>
<P>We updated references (deleted Westfal 1996; added <LINK REF="REF-McNally-2011" TYPE="REFERENCE">McNally 2011</LINK>)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-02-15 10:50:21 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="15" MONTH="2" YEAR="2016"/>
<DESCRIPTION>
<P>This review is the second update of a previous Cochrane systematic review (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>) that included 4 trials and 1 abstract reporting on 481 participants. The first update of 2012 (<LINK REF="REF-Arrich-2012" TYPE="REFERENCE">Arrich 2012</LINK>) included the same studies and participants</P>
<P>In the previous version (<LINK REF="REF-Arrich-2012" TYPE="REFERENCE">Arrich 2012</LINK>), we searched the databases until July 2011. In this updated version, we reran searches to May 2015. Since that time, 1 randomized controlled trial (RCT) was published (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) and we have gained more information on another RCT (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>), so that we were able to include it in the main analysis</P>
<P>We had to limit the individual patient data (IPD) analysis to subgroup analyses</P>
<P>The conclusion for the primary outcome of "neurological outcome" has not changed substantially</P>
<P>No review authors have joined or left the team</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="31" MONTH="7" YEAR="2012"/>
<DESCRIPTION>
<P>We added Christof Havel as a review author</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="31" MONTH="7" YEAR="2012"/>
<DESCRIPTION>
<P>This review is an update of a previous Cochrane systematic review (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>) that included 4 trials and 1 abstract reporting on 481 participants</P>
<P>In the previous version (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>), we searched the databases until January 2009. In this updated version, we reran searches to July 2011</P>
<P>We updated Methods, allocated all chapters, updated references and added a risk of bias table and a summary of findings table</P>
<P>A typing error (survival instead of neurological outcome) in the Results section was spotted by a reader and was corrected accordingly</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="28" MONTH="6" YEAR="2010"/>
<DESCRIPTION>
<P>We updated contact details</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<DATE DAY="29" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>We corrected a typo in a co-review author's address (Müllner)</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Medical University of Vienna</NAME>
<COUNTRY CODE="AT">Austria</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-02-15 10:58:28 +0000" MODIFIED_BY="Jane Cracknell">
<SUMMARY MODIFIED="2016-02-15 10:53:18 +0000" MODIFIED_BY="Jane Cracknell">
<TITLE MODIFIED="2015-11-23 21:08:52 +0000" MODIFIED_BY="Jasmin ">Cooling the body after resuscitation following cardiac arrest</TITLE>
<SUMMARY_BODY MODIFIED="2016-02-15 10:53:18 +0000" MODIFIED_BY="Jane Cracknell">
<P>
<B>Review question</B>
</P>
<P>In this review, we asked whether people resuscitated from cardiac arrest benefit when their bodies are cooled to a temperature of 34°C or lower.</P>
<P>
<B>Background</B>
</P>
<P>
<I>Population and outcomes</I>
</P>
<P>Around 30% to 50% of all people with coronary heart disease suffer sudden cardiac death at some stage of their illness. Sudden cardiac death means that the heart and subsequently the circulation stop. If these people are not resuscitated, brain cells begin to be irreversibly damaged, and subsequently the person dies. After resuscitation, treatment within the first few hours is critical for avoiding or limiting brain damage. One form of therapy that may help to prevent cell damage consists of cooling the body for several hours after successful resuscitation to 34°C or lower.</P>
<P>
<B>Intervention</B>
</P>
<P>We compared people who had their bodies cooled to 32°C to 34°C or below after resuscitation with people who were not cooled following successful resuscitation.</P>
<P>
<B>Search date</B>
</P>
<P>Evidence is current to May 2015.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We included in our analysis six studies (1412 people overall), four of which (437 people) examined effects of cooling the body by conventional methods after successful resuscitation for cardiac arrest. One study that used haemofiltration (cooling the blood externally - similar to dialysis) as the cooling method and one study in which cooling to 33°C was compared with temperature management at 36°C were treated separately in the review.</P>
<P>
<B>Study funding sources</B>
</P>
<P>The study that used external cooling was supported by a dialysis-related company. Of the five studies included in the main analysis, two received funding from government or non-profit organizations; three studies did not provide information on funding.</P>
<P>
<B>Key results</B>
</P>
<P>When we compared people whose bodies were cooled to 32°C to 34°C after resuscitation versus those whose bodies were not cooled at all, we found that 63% of those receiving cooling would suffer no, or only minor, brain damage, while only 33% of those not cooled would suffer no, or only minor, brain damage. Cooling had an important effect on simple survival, with or without brain damage: 57% would survive if their bodies were cooled compared with 42% if their bodies were not cooled at all. No serious side effects occurred, but cooling the body was associated with increased risk of pneumonia (49% vs 42% of those studied) and increased risk of low concentrations of potassium in the blood (18% vs 13%).</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>Some studies had quality shortcomings including small numbers of participants and use of inadequate methods to balance participants between intervention and control groups. However, when differences between studies are acknowledged (heterogeneity), it is clear that these shortcomings had no major impact on the main results.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<ABS_BACKGROUND MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Good neurological outcome after cardiac arrest is difficult to achieve. Interventions during the resuscitation phase and treatment within the first hours after the event are critical. Experimental evidence suggests that therapeutic hypothermia is beneficial, and several clinical studies on this topic have been published. This review was originally published in 2009; updated versions were published in 2012 and 2016.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We aimed to perform a systematic review and meta-analysis to assess the influence of therapeutic hypothermia after cardiac arrest on neurological outcome, survival and adverse events.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We searched the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL<I>; </I>2014, Issue 10<I>)</I>; MEDLINE (1971 to May 2015); EMBASE (1987 to May 2015); the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1988 to May 2015); and BIOSIS (1989 to May 2015). We contacted experts in the field to ask for information on ongoing, unpublished or published trials on this topic.The original search was performed in January 2007.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included all randomized controlled trials (RCTs) conducted to assess the effectiveness of therapeutic hypothermia in participants after cardiac arrest, without language restrictions. We restricted studies to adult populations cooled by any cooling method, applied within six hours of cardiac arrest.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We entered validity measures, interventions, outcomes and additional baseline variables into a database. Meta-analysis was performed only for a subset of comparable studies with negligible heterogeneity. We assessed the quality of the evidence by using standard methodological procedures as expected by Cochrane and incorporated the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We found six RCTs (1412 participants overall) conducted to evaluate the effects of therapeutic hypothermia - five on neurological outcome and survival, one on only neurological outcome. The quality of the included studies was generally moderate, and risk of bias was low in three out of six studies. When we compared conventional cooling methods versus no cooling (four trials; 437 participants), we found that participants in the conventional cooling group were more likely to reach a favourable neurological outcome (risk ratio (RR) 1.94, 95% confidence interval (CI) 1.18 to 3.21). The quality of the evidence was moderate.</P>
<P>Across all studies that used conventional cooling methods rather than no cooling (three studies; 383 participants), we found a 30% survival benefit (RR 1.32, 95% CI 1.10 to 1.65). The quality of the evidence was moderate.</P>
<P>Across all studies, the incidence of pneumonia (RR 1.15, 95% CI 1.02 to 1.30; two trials; 1205 participants) and hypokalaemia (RR 1.38, 95% CI 1.03 to 1.84; two trials; 975 participants) was slightly increased among participants receiving therapeutic hypothermia, and we observed no significant differences in reported adverse events between hypothermia and control groups. Overall the quality of the evidence was moderate (pneumonia) to low (hypokalaemia).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Evidence of moderate quality suggests that conventional cooling methods provided to induce mild therapeutic hypothermia improve neurological outcome after cardiac arrest, specifically with better outcomes than occur with no temperature management. We obtained available evidence from studies in which the target temperature was 34°C or lower. This is consistent with current best medical practice as recommended by international resuscitation guidelines for hypothermia/targeted temperature management among survivors of cardiac arrest. We found insufficient evidence to show the effects of therapeutic hypothermia on participants with in-hospital cardiac arrest, asystole or non-cardiac causes of arrest<I>.</I>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-02-15 10:58:28 +0000" MODIFIED_BY="Jane Cracknell">
<BACKGROUND MODIFIED="2016-02-15 10:53:49 +0000" MODIFIED_BY="Jane Cracknell">
<CONDITION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>The incidence of out-of-hospital sudden cardiac arrest in industrial countries varies greatly over different study groups and is reported to range between 0.05% and 0.19% per year (<LINK REF="REF-Chugh-2004" TYPE="REFERENCE">Chugh 2004</LINK>; <LINK REF="REF-McNally-2011" TYPE="REFERENCE">McNally 2011</LINK>; <LINK REF="REF-Rea-2004" TYPE="REFERENCE">Rea 2004</LINK>). Among all participants for whom resuscitation was attempted, 14% to 40% achieved return of spontaneous circulation and were admitted to hospital (<LINK REF="REF-Finn-2001" TYPE="REFERENCE">Finn 2001</LINK>; <LINK REF="REF-Fischer-1997" TYPE="REFERENCE">Fischer 1997</LINK>; <LINK REF="REF-Giraud-1996" TYPE="REFERENCE">Giraud 1996</LINK>; <LINK REF="REF-Herlitz-2003b" TYPE="REFERENCE">Herlitz 2003b</LINK>; <LINK REF="REF-Kuisma-1996" TYPE="REFERENCE">Kuisma 1996</LINK>; <LINK REF="REF-Leung-2001" TYPE="REFERENCE">Leung 2001</LINK>; <LINK REF="REF-Rewers-2000" TYPE="REFERENCE">Rewers 2000</LINK>). Of patients admitted to hospital, only between 7% and 30% were discharged from hospital with good neurological outcome (<LINK REF="REF-Absalom-1999" TYPE="REFERENCE">Absalom 1999</LINK>; <LINK REF="REF-B_x00f6_ttiger-1999" TYPE="REFERENCE">Böttiger 1999</LINK>; <LINK REF="REF-Fischer-1997" TYPE="REFERENCE">Fischer 1997</LINK>; <LINK REF="REF-Herlitz-1999" TYPE="REFERENCE">Herlitz 1999</LINK>; <LINK REF="REF-Jennings-2001" TYPE="REFERENCE">Jennings 2001</LINK>; <LINK REF="REF-McNally-2011" TYPE="REFERENCE">McNally 2011</LINK>; <LINK REF="REF-Weston-1997" TYPE="REFERENCE">Weston 1997</LINK>). To improve neurological outcome and survival of patients after cardiac arrest, providers have applied many methods related to post-resuscitation care. These comprise optimizing haemodynamics and providing ventilation, coronary reperfusion, electrolytes, seizure control, temperature management and glucose control and are summarized in the main resuscitation guidelines (<LINK REF="REF-Callaway-2015" TYPE="REFERENCE">Callaway 2015</LINK>; <LINK REF="REF-Soar-2015" TYPE="REFERENCE">Soar 2015</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Therapeutic hypothermia (or targeted temperature management/induced hypothermia) is still a relatively new concept for preservation of cerebral function among patients resuscitated from cardiac arrest. After the patient's condition has been stabilized, body temperature is lowered to 32°C to 34°C for a duration of 24 hours. Conventional cooling comprises surface cooling methods requiring cooling pads, ice packs, water immersion or intravascular cooling with cooling catheters or simply cold fluids. Cooling can be combined with haemofiltration or extracorporeal cardiopulmonary support.</P>
</INTERVENTION>
<THEORY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Therapeutic hypothermia is believed to work in many ways. Cerebral reperfusion after successful resuscitation, although essential and effective in restoring energy stores, can trigger harmful chemical cascades. Generation of free radicals and other mediators, which leads to multi-focal damage to the brain, was first described by Negovsky as "post-resuscitation syndrome" (<LINK REF="REF-Negovsky-1988" TYPE="REFERENCE">Negovsky 1988</LINK>). In contrast to accidental hypothermia, therapeutic mild hypothermia (32°C to 34°C) is administered in a controlled way. Intra-ischaemic hypothermia for brain protection has been provided for several years with certain surgical procedures and circulatory arrest states. Clinical and experimental results show protective effects of hypothermia during and after ischaemic situations (<LINK REF="REF-Rosomoff-1954" TYPE="REFERENCE">Rosomoff 1954</LINK>). Therapeutic hypothermia can inhibit the biosynthesis, release and uptake of several catecholamines and neurotransmitters (<LINK REF="REF-Okuda-1986" TYPE="REFERENCE">Okuda 1986</LINK>; <LINK REF="REF-Sun-2010" TYPE="REFERENCE">Sun 2010</LINK>; <LINK REF="REF-Szelenyi-2012" TYPE="REFERENCE">Szelenyi 2012</LINK>), especially glutamate and dopamine, thus preventing potential tissue damage (<LINK REF="REF-D_x0027_Cruz-2002" TYPE="REFERENCE">D'Cruz 2002</LINK>; <LINK REF="REF-Hachimi_x002d_Idrissi-2004" TYPE="REFERENCE">Hachimi-Idrissi 2004</LINK>). Other beneficial effects of hypothermia include preservation of the blood-brain barrier (<LINK REF="REF-Baumann-2009" TYPE="REFERENCE">Baumann 2009</LINK>; <LINK REF="REF-Karibe-1994" TYPE="REFERENCE">Karibe 1994</LINK>); protection of adenosine triphosphate (ATP) stores (<LINK REF="REF-McCullough-1999" TYPE="REFERENCE">McCullough 1999</LINK>; <LINK REF="REF-Mizuhara-1996" TYPE="REFERENCE">Mizuhara 1996</LINK>) necessary for energy provision; restitution of post-ischaemic cerebral microcirculation (<LINK REF="REF-Takasu-1996" TYPE="REFERENCE">Takasu 1996</LINK>); and possibly decreased intracranial pressure (<LINK REF="REF-Lee-2010" TYPE="REFERENCE">Lee 2010</LINK>; <LINK REF="REF-Schreckinger-2009" TYPE="REFERENCE">Schreckinger 2009</LINK>). Subsequently, hypothermia seems to act in a multi-factorial way by influencing several damaging pathways simultaneously (<LINK REF="REF-Holzer-2010" TYPE="REFERENCE">Holzer 2010</LINK>) to reduce cell death within the brain.</P>
</THEORY>
<IMPORTANCE MODIFIED="2016-02-15 10:53:49 +0000" MODIFIED_BY="Jane Cracknell">
<P>The first Cochrane review (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>) was conducted to examine the emergence of mild therapeutic hypothermia as part of routine care for survivors of cardiac arrest. Two randomized controlled trials (RCTs) had shown that induced hypothermia has a neuroprotective effect in patients primarily resuscitated from cardiac arrest (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>), and therapeutic hypothermia was recommended in the guidelines of the International Liaison Committee on Resuscitation (ILCOR) (<LINK REF="REF-Nolan-2003" TYPE="REFERENCE">Nolan 2003</LINK>) and in other resuscitation guidelines of that time (<LINK REF="REF-Deakin-2010" TYPE="REFERENCE">Deakin 2010</LINK>; <LINK REF="REF-Peberdy-2010" TYPE="REFERENCE">Peberdy 2010</LINK>). It is recommended as "targeted temperature management (induced hypothermia)" in the current resuscitation guidelines (<LINK REF="REF-Callaway-2015" TYPE="REFERENCE">Callaway 2015</LINK>; <LINK REF="REF-Soar-2015" TYPE="REFERENCE">Soar 2015</LINK>). Therapeutic hypothermia remains a relatively new concept. Studies examining different treatment modalities are emerging; therefore systematic and regular updates of the literature are important for monitoring new and effective developments. A recent publication following a large RCT on two different cooling levels described no differences between the two treatment regimens (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). We present the second update of the original Cochrane review (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>; <LINK REF="REF-Arrich-2012" TYPE="REFERENCE">Arrich 2012</LINK>), which incorporates up-to-date evidence.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We aimed to perform a systematic review and meta-analysis to assess the influence of therapeutic hypothermia after cardiac arrest on neurological outcome, survival and adverse events.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-02-15 10:58:28 +0000" MODIFIED_BY="Jane Cracknell">
<SELECTION_CRITERIA MODIFIED="2016-02-15 10:54:24 +0000" MODIFIED_BY="Jane Cracknell">
<CRIT_STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included randomized and 'quasi-randomized' controlled trials. 'Quasi-randomized' refers to allocation procedures such as alternating days, odd and even days and the like.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-02-03 15:14:01 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included studies in adult participants who suffered from cardiac arrest (regardless of whether in-hospital or out-of-hospital cardiac arrest) and were successfully resuscitated.</P>
<P>We excluded studies of children and adolescents (younger than 18 years), as presumed causes of cardiac arrest are different from causes in adults.</P>
<P>Although participants with a prior neurological history may not greatly benefit from the intervention, we did not exclude them for the following reasons.</P>
<UL>
<LI>The number of such participants is most likely negligible.</LI>
<LI>In a real-life situation, information on neurological performance before cardiac arrest often is not available when post-resuscitation therapy is initiated</LI>
</UL>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-02-15 10:54:24 +0000" MODIFIED_BY="Jane Cracknell">
<P>The intervention of interest was therapeutic hypothermia - regardless of how body temperature was reduced - applied within six hours of arrival at hospital. We defined 'therapeutic' as any target body temperature of 34°C or lower. We defined the 'control' intervention as standard treatment (at the time of the trial) provided after cardiac arrest.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>The primary outcome measure was neurological recovery. We expected the ideal outcome to be reported as best neurological outcome during hospital stay and in cerebral performance categories (CPCs) (<LINK REF="REF-Stiell-2009" TYPE="REFERENCE">Stiell 2009</LINK>). CPC categories are defined as follows.</P>
<UL>
<LI>Good cerebral performance: conscious, alert, capable of normal life. Normal cerebral function. May have minor psychological or neurological deficits that do not significantly compromise cerebral or physical function.</LI>
<LI>Moderate cerebral disability: conscious, alert, sufficient cerebral function for activities of daily life (e.g. dress, travel by public transportation, food preparation). May have hemiplegia, seizures, ataxia, dysarthria, dysphasia or permanent memory or mental changes.</LI>
<LI>Severe cerebral disability: conscious, with at least limited cognition. Dependent on others for daily life support (i.e. institutionalised or at home with exceptional family effort) because of impaired brain function. Includes individuals with wide range of cerebral abnormalities, from ambulatory participants with severe memory disturbance or dementia precluding independent existence to paralysed participants who can communicate only with their eyes (e.g. the locked-in syndrome).</LI>
<LI>Coma or vegetative state: not conscious, unaware of surroundings, no cognition. No verbal or psychological interaction with environment. May appear awake because of spontaneous eye opening or sleep-wake cycle. Includes individuals showing all degrees of unresponsiveness that are neither CPC three (conscious) nor CPC five (coma, which satisfies brain death criteria).</LI>
<LI>Certified brain death.</LI>
</UL>
<P>If study authors grouped the primary outcome into one or two (good recovery) and three to five (unfavourable recovery), we adapted it for our meta-analysis. If the primary outcome was not reported in CPC categories, we accepted reports of 'good' neurological outcome, and we assumed that this was comparable with a CPC score of one or two.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<UL>
<LI>Survival to hospital discharge at six months and long term.</LI>
<LI>Quality of life at six months and long term.</LI>
<LI>Dependency.</LI>
<LI>Cost-effectiveness.</LI>
</UL>
<P>We defined 'long term' as a minimum of one year.</P>
<SUBSECTION>
<HEADING LEVEL="5">Adverse events</HEADING>
<P>We aimed to report adverse events as described by study authors.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-02-15 10:58:28 +0000" MODIFIED_BY="Jane Cracknell">
<ELECTRONIC_SEARCHES MODIFIED="2016-02-15 10:58:28 +0000" MODIFIED_BY="Jane Cracknell">
<P>We searched the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL<I>; </I>2014, Issue 9); MEDLINE (1971 to May 2015); EMBASE (1987 to May 2015); the Cumulative Index to Nuring and Allied Health Literature (CINAHL) (1988 to May 2015); and BIOSIS (1989 to May 2015). Original searches were performed in January 2007 (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>) and were updated in July 2011 (<LINK REF="REF-Arrich-2012" TYPE="REFERENCE">Arrich 2012</LINK>) .</P>
<P>We performed searches by entering search terms as multiple postings (.mp, term appears in the title, abstract or medical subject heading (MeSH)) and some as medical subject headings (MeSH) for MEDLINE and exploded terms for EMBASE and CINAHL (search terms for CENTRAL, <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; MEDLINE, <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>; EMBASE, <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>; CINAHL, <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>; BIOSIS, <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>). We used a search strategy for identifying RCTs with MEDLINE, CINAHL and EMBASE (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and we applied no language restrictions. We searched three trials registers as well: <A HREF="https://eudract.ema.europa.eu/">EudraCT</A>; <A HREF="http://ClinicalTrials.gov">ClinicalTrials.gov</A>; <A HREF="http://www.who.int/ictrp/">International Clinical Trials Registry Platform</A>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>In an attempt to identify additional studies, we asked experts in the field whether they were aware of any ongoing, unpublished or published trials on this topic.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY_SELECTION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We imported all retrieved results into EndNote (version X5; Thomson Corporation, Stamford, CT, USA) and eliminated duplicates. Two review authors (JA, MH or CH; HH as arbiter in case of discrepancies) independently scanned each reference for inclusion in the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We independently extracted data using a data extraction form (see <LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>). As we intended to use the original individual patient data (IPD) provided by identified trials, we contacted the respective corresponding authors and asked for collaboration. Two review authors independently entered all relevant data into the Cochrane software program Review Manager (<LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>). We compared the two versions and resolved disagreements by discussion.</P>
<P>We entered the following variables into <LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>.</P>
<UL>
<LI>Study characteristics.</LI>
<LI>Data on outcomes.</LI>
<LI>Items on risk of bias.</LI>
<LI>Within-study subgroup effect estimates as calculated from IPD outside RevMan.</LI>
</UL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>To assess the internal validity of identified trials, we assessed allocation sequence generation, allocation concealment, blinding of outcome assessment, exclusion of randomized participants from the analysis, comparability of groups, loss to follow-up and other potential sources of bias. However, blinding of treating personnel regarding application of therapeutic hypothermia was considered almost impossible.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We calculated risk ratios (RRs) and their 95% confidence intervals (CIs).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We did not include cluster-randomized trials in the analysis; in the case of multiple treatment groups, we planned to combine groups to create a single comparison; by nature of the condition and outcomes, we identified no cross-over trials.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>All analyses were performed according to the intention-to-treat (ITT) principle. If data were missing, we attempted to obtain the information by contacting study authors. We included assessment of loss to follow-up in our quality assessment and reported this in the table <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. If a considerable quantity of data was missing, we would investigate the possible mechanism of the missing data (whether random or not). We planned to perform a sensitivity analysis to assess the influence of this possible selection bias on our estimates.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We assessed data for clinical and statistical heterogeneity. We performed quantitative synthesis of data only if clinical heterogeneity was negligible. Clinical heterogeneity may be caused by differences in study populations, interventions and controls, or by variable definitions of the endpoint (<LINK REF="REF-Thompson-2001" TYPE="REFERENCE">Thompson 2001</LINK>). Pooling of data may not be suitable in cases of severe heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We assessed the presence of possible publication bias and heterogeneity by using funnel plots (plotting effect vs precision) (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>) and planned to present this information if we identified more than10 studies.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Quantitative analysis of IPD was intended when studies showed negligible heterogeneity and IPD were available at least for a clinically uniform subset. In the case that IPD were not available for at least one study, we planned to perform an analysis at the study level, particularly when we encountered updates. We planned to perform a quantitative synthesis of IPD by using standard statistical procedures provided in <LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>. The principal summary effect estimate was the risk ratio with a 95% confidence interval.</P>
<P>In the case of negligible heterogeneity, we used a fixed-effect model to calculate summary effects; otherwise we used random-effects models. We assessed statistical heterogeneity by using the I<SUP>2</SUP> statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>) and considered statistical heterogeneity relevant with I<SUP>2</SUP> statistic &gt; 50%.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>For the primary endpoint and for survival, we performed subgroup analyses at the study level.</P>
<UL>
<LI>Treatment of the control group: no cooling versus temperature management. These ancillary analyses were introduced at the current update following consideration of differences in control group treatment described in a newly included study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). We used the standard test for subgroup differences to assess differences in effects between study level subgroups.</LI>
</UL>
<P>When data became available, we performed subgroup analyses for the primary outcome using IPD. We used the following variables.<BR/>
</P>
<UL>
<LI>Cause of cardiac arrest (presumed cardiac vs non-cardiac).</LI>
<LI>Location of arrest (in-hospital vs out-of-hospital).</LI>
<LI>Witnessed versus non-witnessed arrest.</LI>
<LI>Primary electrocardiography (ECG) rhythm (ventricular fibrillation vs other).</LI>
</UL>
<P>We received IPD (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>) via spreadsheets including participant-specific information on interventions, outcomes and subgroup properties. We calculated subgroup-specific effect estimates across included studies at the individual patient level but performed no tests to examine subgroup differences.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We performed sensitivity analyses to examine the impact of study quality issues, as measured by allocation concealment, on overall effect estimates and on effect sizes of all identified trials without consideration of heterogeneity and publication status. To investigate whether model choice might influence our results, we compared estimates derived from random-effects models versus those obtained from fixed-effect models.</P>
<SUBSECTION>
<HEADING LEVEL="3">
<I>Summary of findings</I>
</HEADING>
<P>We used the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach to interpret findings (<LINK REF="REF-Langendam-2013" TYPE="REFERENCE">Langendam 2013</LINK>). The GRADE profiler (<LINK REF="REF-GRADEPRO" TYPE="REFERENCE">GRADEPRO</LINK>) allowed us to import data from Review Manager (<LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>) to create a 'Summary of findings' table. This table provides outcome-specific information concerning overall quality of evidence gathered from studies included in the comparison, magnitude of effects of the interventions examined and the sum of available data on outcomes considered.</P>
<P>We included the following outcomes in a 'Summary of findings' table.</P>
<UL>
<LI>Neurological outcome, survival (conventional cooling vs no cooling) and adverse events (vs no cooling and 36°C).</LI>
</UL>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-02-03 15:14:02 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY_DESCRIPTION MODIFIED="2016-02-03 15:13:35 +0000" MODIFIED_BY="Jane Cracknell">
<SEARCH_RESULTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Our original and updated searches (from 2007 to May 2015) resulted in 2425 hits (duplicates excluded). From these, we excluded 2417 according to our eligibility criteria (randomized studies on adult participants with cardiac arrest treated with therapeutic hypothermia) by judging the abstract or the title. Eight papers remained for closer inspection. Of those, we excluded three after further evaluation (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>; and <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). Upon looking through the references of a systematic review on therapeutic hypothermia (<LINK REF="REF-Cheung-2006" TYPE="REFERENCE">Cheung 2006</LINK>), we found one additional reference, published only as an abstract (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>). Hence overall, six randomized and quasi-randomized controlled trials with a total of 1412 participants remained for analysis (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>The decision on inclusion of one study was not unequivocal (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) because control group participants in the study by Nielsen et al received active temperature management at 36°C, which is clearly different from 'no temperature management'. It is a matter of concern whether temperature control at 36°C can be seen as 'standard therapy', as we outlined in our inclusion criteria for the control group. We decided to include the study in our review while treating it as a separate subgroup for the main analysis. However, in an additional ancillary analysis, we calculated a pooled overall estimate to inform the current controversial discussion.</P>
<P>We found that one previously unclassified study (<LINK REF="REF-Tiainen-2007" TYPE="REFERENCE">Tiainen 2007</LINK>) and two additional studies (<LINK REF="REF-Tiainen-2003" TYPE="REFERENCE">Tiainen 2003</LINK>; <LINK REF="REF-Tiainen-2005" TYPE="REFERENCE">Tiainen 2005</LINK>) were reports of the <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> study.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-02-03 15:13:35 +0000" MODIFIED_BY="Jane Cracknell">
<P>We included six studies (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>) in this updated review.</P>
<P>The first study (<LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>) was a feasibility RCT carried out at one 700-bed teaching hospital in Brussels during a six month period. It included 33 consecutive participants with out-of-hospital cardiac arrest and asystole or pulseless electrical activity (PEA) of presumed cardiac origin who achieved return of spontaneous circulation (ROSC). The mean age of participants was 72, and 39% were female. After admission and stabilization, participants were randomly assigned to (1) a helmet device placed around the head and neck containing a solution of aqueous glycerol, or (2) standard therapy without hypothermia. The target temperature of the intervention group was 34°C, which should be maintained over a period of four hours; this was followed by a passive rewarming phase over eight hours. Outcome parameters were laboratory values and haemodynamics, survival to hospital discharge and overall performance categories (OPCs) and adverse events. No information on funding was provided.</P>
<P>Two studies were published at the same time (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>). The study by <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK> was a quasi-RCT carried out by the ambulance service of Melbourne and four adjacent emergency departments and intensive care units over a three-year period. It included 77 participants with out-of-hospital cardiac arrest and ventricular fibrillation as first cardiac rhythm who were comatose after they achieved ROSC. The mean age of participants was 66, and 33% were female. Participants were randomly assigned by the ambulance staff to receive (1) therapeutic hypothermia by ice packs placed around the head, neck, torso and limbs, or (2) standard therapy without hypothermia. The target temperature of the intervention group was 33°C, which should be maintained over a period of 24 hours; this was followed by a passive rewarming phase over eight hours. Outcome parameters were survival with good neurological function; in-hospital mortality; haemodynamic, biochemical and haematological effects of hypothermia; and adverse events. No information on funding was provided.</P>
<P>
<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> was an RCT carried out by nine centres in five European countries and four adjacent emergency departments and intensive care units over a five-year period. It included 275 participants with out-of-hospital bystander-witnessed cardiac arrest of presumed cardiac cause, ventricular fibrillation or non-perfusing ventricular tachycardia as first cardiac rhythm, who were comatose after resuscitation. The mean age of participants was 59, and 24% were female. After admission, participants were randomly assigned to receive (1) therapeutic hypothermia by an external cooling device, or (2) standard therapy without hypothermia. The target temperature of the intervention group was 32°C to 34°C, which should be maintained over a period of 12 hours; this was followed by a passive rewarming phase over 12 hours and, if necessary, active rewarming after 18 hours. Outcome parameters were survival, neurological outcome and adverse events. Funding was provided by grants of the Fourth Research and Technological Development (RTD) Framework Programme 1994 to 1998 of the European Union (<LINK REF="REF-Fourth-Framework-Programme" TYPE="REFERENCE">Fourth Framework Programme</LINK>), the Austrian Ministry of Science and Transport and the Austrian Science Foundation (<LINK REF="REF-FWF" TYPE="REFERENCE">FWF</LINK>).</P>
<P>
<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK> was an RCT carried out at two intensive care units in Paris over a two-year period. It included 42 participants with out-of-hospital cardiac arrest of presumed cardiac cause, ventricular fibrillation or asystole as first cardiac rhythm, who were comatose after resuscitation. The mean age of participants was 52 to 56 years, and 19% were female. After admission, participants were randomly assigned to receive (1) high-flow haemofiltration, (2) high-flow haemofiltration plus therapeutic hypothermia or (3) standard therapy without hypothermia. The target temperature of the intervention group was 32°C to 34°C, which should be maintained over a period of 24 hours; this was followed by a passive rewarming phase over 12 hours. Outcome parameters were survival, neurological outcome and adverse events. For this study, haemofiltration circuits, catheters and replacement fluid concentrates were provided by GAMBRO (<LINK REF="REF-GAMBRO" TYPE="REFERENCE">GAMBRO</LINK>).</P>
<P>
<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK> was published as an abstract with additional information provided by study authors. It was carried out at a University hospital in Sapporo, Japan, and included 54 participants with out-of-hospital cardiac arrest with a Glasgow Coma Scale (GCS) score less than eight after resuscitation. After admission, participants were randomly assigned to receive (1) therapeutic hypothermia by water-circulating blankets above and below the participant with another ice mounted blanket over the participant, or (2) standard therapy without hypothermia. The target temperature of the intervention group was 32°C to 34°C, which should be maintained over a period of three days. The reported outcome parameter was neurological outcome. Study authors provided no information on funding.</P>
<P>
<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>, which was published recently, was carried out at 36 intensive care units (ICUs) in Europe and Australia over a three-year period. It included 950 adults with out-of-hospital cardiac arrest of presumed cardiac cause and sustained return of spontaneous circulation who were comatose after resuscitation (GCS &lt; 8). The mean age of participants was 64 years, and 19% were female. After admission, participants were randomly assigned to receive (1) temperature management at 33°C (method of choice was up to the discretion of treating physicians), or (2) temperature management at 36°C (method of choice was up to the discretion of treating physicians). The target temperature of the intervention group was 32°C to 34°C, which should be maintained over a period of 24 hours; this was followed by a rewarming phase over eight hours. Outcome parameters were survival and neurological and functional outcomes. Funding was provided by the Swedish Heart&#8211;Lung Foundation and others.</P>
<SUBSECTION>
<HEADING LEVEL="5">
<I>Clinical heterogeneity</I>
</HEADING>
<P>We identified clinical heterogeneity due to cooling methods. In contrast to the other studies, <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK> used haemofiltration as the mode of cooling, which is substantially different from the standard cooling methods used in the other RCTs; therefore, we did not pool data with those from remaining studies. We now successfully contacted Kazuhisa Mori and Eric Dickson, who provided relevant details of their study (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>). On the basis of cooling methods and clinical characteristics, the remaining four studies appeared appropriate for pooling in the main analysis (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We excluded three studies; one was a substudy to the <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> trial that provided no extra information relevant to our review (<LINK REF="STD-CAEP_x002f_ACMU-2013" TYPE="STUDY">CAEP/ACMU 2013</LINK>), and for two, inclusion criteria for the intervention or control group did not apply (<LINK REF="STD-Lopez_x002d_de_x002d_Sa-2012" TYPE="STUDY">Lopez-de-Sa 2012</LINK>; <LINK REF="STD-Takeda-2009" TYPE="STUDY">Takeda 2009</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>We identified no ongoing studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Awaiting classification</HEADING>
<P>No studies are awaiting classification.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We assessed each included trial by using the following criteria: mode of randomization, allocation concealment, level of blinding, loss to follow-up, comparability of groups and use of measures to account for differences between groups (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Risk of bias in the included studies was generally low, with relevant deficits noted in three out of six studies.</P>
<P>Except for the abstract (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>), all studies reported on almost all essential quality criteria, and loss to follow-up was within an acceptable range. One study showed deficits in the randomization process and adjustments made for inequalities in baseline characteristics between treatment and control groups (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>). Follow-up was generally good in the included studies. In <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>, hypothermia was discontinued in 14 participants because of death, arrhythmia, haemodynamic instability and technical problems with the cooling device;in one case because of liver rupture; in another because a randomly assigned participant had already been included in the study before cooling, and in another case because of an error in the duration of cooling. These participants were included in the intention-to-treat analysis of primary and secondary outcomes.</P>
<ALLOCATION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Three trials (<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>) reported adequate randomization methods and use of opaque envelopes to conceal treatment allocation.</P>
</ALLOCATION>
<BLINDING MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Three trials reported blinded outcome assessment (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>One study lost information on two participants for the primary endpoint (<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>). All other studies reported complete follow-up.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We found no indication of selective outcome reporting.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>In two studies, treatment and control groups did not differ significantly in terms of reported baseline characteristics (<LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>), although <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK> included rather small groups.</P>
<P>
<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> described baseline differences between groups. Participants in the normothermia group were more likely to have a history of diabetes mellitus or coronary heart disease, and to have received basic life support from a bystander, than were those in the hypothermia group. Study authors adjusted for all baseline variables, and the risk ratio increased slightly, from 1.40 (95% CI 1.08 to 1.81) to 1.47 (95% CI 1.09 to 1.82).</P>
<P>
<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK> reported differences in sex and rate of bystander cardiopulmonary resuscitation between groups but did not adjust for this possible bias.</P>
<P>
<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK> provided no information on baseline characteristics of participant groups.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-02-03 15:14:02 +0000" MODIFIED_BY="Jane Cracknell">
<SUBSECTION>
<HEADING LEVEL="3">Primary outcome</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Good neurological outcome</HEADING>
<P>With four studies (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>) (437 participants) reporting on conventional cooling methods compared with no cooling, the pooled result showed a better neurological outcome for the conventional cooling group (RR 1.94, 95% CI 1.18 to 3.21; I<SUP>2 </SUP>statistic = 47%; see <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>; and <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>). The quality of the evidence was moderate. We downgraded the quality of the evidence as the result of imprecision. One study included 42 participants undergoing haemofiltration after cardiac arrest (<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>); this introduced considerable clinical heterogeneity and prevented pooling with the studies described above. Cooling using haemofiltration did not result in a difference in good neurological outcome (RR 0.71, 95% CI 0.32 to 1.54; see <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). The quality of the evidence was very low. We downgraded the quality of the evidence as the result of risk of bias, imprecision and indirectness. Another study evaluated the effects of conventional cooling versus targeted temperature management at 36°C (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). Investigators (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) noted no effects on neurological outcome if therapeutic hypothermia at 33°C was compared with temperature management at 36°C (RR 0.97, 95% CI 0.85 to 1.11; 933 participants; see <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>). The quality of the evidence was moderate. We downgraded the quality of the evidence for this single but large RCT as the result of indirectness.</P>
<P>When data from all studies that used conventional cooling methods regardless of the control treatment (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) were pooled, cooling to 33°C was still superior to no cooling or temperature management at 36°C (RR 1.53, 95% CI 1.02 to 2.29; P value = 0.04; see <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). However, we found considerable heterogeneity when pooling all of these studies (heterogeneity: tau² = 0.12; Chi² = 17.28; df = 4 (P value = 0.002); I² statistic = 77%), possibly because a different control group treatment was given in one study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). The test for subgroup differences according to control group treatment (no cooling vs target temperature at 36°C) was highly positive (Chi² = 6.84; df = 1 (P value = 0.009)). Cautious interpretation of this effect is therefore warranted, but to inform the current discussion, we present the pooled estimate for the primary outcome despite obvious limitations here and restrict the summary of findings to findings with the least ambiguity (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Subgroup analyses - IPD level</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Influence of cardiac arrest conditions</HEADING>
<P>According to the number of participants and information provided by study authors, we formed subgroups of the meta-analysis by using the following variables: cause of cardiac arrest (presumed cardiac vs non-cardiac); location of arrest (in-hospital vs out-of-hospital); witnessed versus non-witnessed arrest; and primary ECG rhythm (ventricular fibrillation (VF) or ventricular tachycardia (VT) vs other). The endpoint was 'best ever reached CPC during hospital stay' (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>).</P>
<UL>
<LI>The risk for participants with a cardiac cause (n = 372; three studies; <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>) and VF or VT was 1.51 (95% CI 1.19 to 1.91; n = 330; two studies; <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>).</LI>
<LI>Groups of participants with non-VF or VT rhythm as the first cardiac rhythm (n = 52; participants with a non-cardiac cause - n = 11, and in-hospital arrests - n = 17) were small and showed no statistically significant effects (non-VF or VT: RR 2.17, 95% CI 0.68 to 6.93; I<SUP>2 </SUP>statistic = 50%; two studies; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>) (non-cardiac cause: RR 3.80, 95% CI 0.55 to 26.29; I<SUP>2</SUP> statistic = 0%; two studies; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>) (in-hospital: RR 1.64, 95% CI 0.47 to 5.73).</LI>
<LI>A small number of participants had non-witnessed arrest (n = 22). Among these participants, effect size was substantially greater than the summary effect for the whole study population (RR 5.31, 95% CI 1.40 to 20.21; I<SUP>2</SUP> statistic = 0%; three studies; <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>).</LI>
<LI>For participants with witnessed cardiac arrest (n = 360), the risk ratio was 1.43 (95% CI 1.13 to 1.81; I<SUP>2</SUP> statistic = 0%; three studies; <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sensitivity analysis</HEADING>
<SUBSECTION>
<HEADING LEVEL="6">Robustness against risk of bias in individual studies</HEADING>
<P>Two out of four studies (445 participants) reported on adequate allocation concealment (<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>); for one study (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>; 54 participants), we had no further information, and in another study, allocation concealment was not adequate (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; 77 participants; see <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Pooling of data for studies in which allocation concealment was adequate or unknown (medium risk) resulted in an effect size that was even augmented (from 1.94 to 2.46; three studies; see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Pooling of data for studies in which allocation concealment was adequate (low risk) led to an effect size that was virtually unchanged (from 1.94 to 1.97; two studies). Overall effects appeared robust against deficits in allocation concealment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Influence of model choice</HEADING>
<P>To investigate whether model choice might influence results, we compared estimates from random-effects models with those from fixed-effect models. The effect estimate as presented in Figure 4 did not change much by model choice (fixed-effect RR 1.67, 95% CI 1.32 to 2.11; random-effects RR 1.94, 95% CI 1.18 to 3.21), indicating that the effect is robust against the model choice.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Publication bias</HEADING>
<P>Currently, identified studies are too few to permit inferences from funnel plots; therefore, we have not presented them in the latest version of this review.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Survival to hospital discharge and at six months</HEADING>
<P>With three studies (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; 383 participants) reporting on conventional cooling methods compared with no cooling, the pooled result showed benefit for survival for the conventional cooling group (RR 1.35, 95% CI 1.10 to 1.65; I<SUP>2</SUP> statistic = 0%; see <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>; and <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK>). The quality of the evidence was moderate. We downgraded the quality of the evidence as the result of imprecision. One study included 42 participants undergoing haemofiltration after cardiac arrest (<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>), which introduced considerable clinical heterogeneity and prevented pooling of data with those of the studies described above. Cooling using haemofiltration did not result in differences in survival (RR 0.71, 95% CI 0.32 to 1.54; see <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). The quality of the evidence was very low. We downgraded the quality of the evidence as the result of risk of bias, imprecision and indirectness. Another study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) evaluated effects of conventional cooling versus targeted temperature management at 36°C and reported no effects on survival when therapeutic hypothermia at 33°C was compared with temperature management at 36°C (RR 0.97, 95% CI 0.86 to 1.10; 939 participants; see <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). The quality of the evidence was moderate. We downgraded the quality of the evidence for this single but large RCT as the result of indirectness.</P>
<P>When all studies that used conventional cooling methods regardless of the control treatment (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) were pooled, we noted no survival benefit (RR 1.07, 95% CI 0.96 to 1.19; see <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). We found considerable heterogeneity when pooling these studies, possibly because a different control group treatment was given in one study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). The test for subgroup differences according to control group treatment (no cooling vs target temperature at 36°C) was highly positive (Chi² = 6.36, df = 1 (P value = 0.01)). Cautious interpretation of this effect is therefore warranted, but to inform the current discussion, we present the pooled estimate for the primary outcome despite obvious limitations. We restricted the summary of findings to findings with the least ambiguity (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Long term survival</HEADING>
<P>We found no data on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Quality of life at six months and long term</HEADING>
<P>We found no data on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Dependency</HEADING>
<P>
<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> reported on the modified Rankin Scale at six months (RR 1.01, 95% CI 0.89 to 1.14; P value = 0.87). We found no additional data on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cost-effectiveness</HEADING>
<P>We found no data on this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events</HEADING>
<P>We included in the analysis all trials that reported on adverse events, regardless of heterogeneity. The following adverse events were reported in five studies (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>; 1358 participants): bleeding of any severity and at various locations, need for platelet transfusions, pneumonia, sepsis, pancreatitis, renal failure or oliguria, haemodialysis, pulmonary oedema, seizures, atrial fibrillation/flutter, lethal or long-lasting arrhythmias, cardiac complications and electrolyte and metabolic imbalances (see <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>).</P>
<P>Two studies with 1205 participants (<LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) reported pneumonia, which was more frequent in the treatment group (RR 1.15, 95% CI 1.02 to 1.30; see <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). The quality of the evidence was moderate. We downgraded the quality of the evidence as the result of indirectness (differences in control groups - no temperature management and 36°C). Hypokalaemia was reported in two studies (<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) including 975 participants and was more frequent in the intervention group (RR 1.38, 95% C 1.03 to 1.84). The quality of the evidence was low. We downgraded the quality of the evidence as the result of very serious indirectness (differences in intervention - conventional cooling and haemofiltration - and control groups). Otherwise, researchers observed no significant differences between groups.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<SUMMARY_OF_RESULTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Evidence from five studies with 1370 participants contributing data to the primary outcomes of this review showed that therapeutic hypothermia with conventional cooling methods improved neurological outcome after cardiac arrest. The impact on survival was less certain, but a strong effect was evident when therapeutic hypothermia was compared with no temperature management.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>All studies reported on the same outcomes and, except for <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>, for which we did not receive further information, all outcome assessors were blinded to treatment (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>; <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). The cerebral performance category (CPC) is well standardized and easy to measure, and gives a crude approximation of the person's ability to perform tasks of daily life. One of its limitations is lack of accuracy when it comes to estimating cognitive functions and personal and social impact of cardiac arrest.</P>
<P>After completing our literature search, we were able to include individual patient data (IPD) for only three out of five eligible studies retrieved (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>). Therefore, we had to omit the IPD analysis and could calculate only subgroup analyses using available data. Subsequently, precision in the subsets of participants was humble and maybe was too low to permit firm conclusions about the subgroups.</P>
<P>One of the challenges of this review was heterogeneity at the study level. In the case of <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>, the two treatment modalities (mild therapeutic hypothermia with and without haemodialysis) were clinically too heterogeneous to be combined with those of other studies. As mentioned in the Background section, one of the theories of the beneficial effects of cooling deals with attenuation of the effects of free radicals and other mediators. Haemofiltration may act in a similar way, by reducing the number of free radicals. This effect is likely to interact with the effect of therapeutic hypothermia.</P>
<P>Control group treatment is another important driver for heterogeneity. <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> differed considerably in terms of control group treatment, as investigators used a target temperature of 36°C in contrast to no temperature management as employed by the other studies. Despite seemingly subtle differences, this can be expressed as two distinct clinical questions: 'Does mild therapeutic hypothermia compared with no mild therapeutic hypothermia at all influence outcome?' versus 'Does temperature management targeted to 33°C compared with 36°C influence outcome?' These questions were often ignored in clinical discussions, however. To meet concerns of heterogeneity and at the same time give a better picture of available data, we decided to perform an ancillary analysis. Without temperature management in the control group, therapeutic hypothermia at 32°C to 34°C improves neurological outcome after cardiac arrest, and this effect persists when the control group receives active temperature management at 36°C. Whether 36°C, cooling to 32°C to 34°C and no cooling are equally effective can be judged only by an indirect comparison. This indirect comparison however should be performed when a sufficient degree of transitivity is present, which is not necessarily the case here (<LINK REF="REF-Storm-2014" TYPE="REFERENCE">Storm 2014</LINK>; <LINK REF="REF-Stub-2014" TYPE="REFERENCE">Stub 2014</LINK>).</P>
<P>In our sensitivity analysis, the effect was robust against allocation concealment and model choice.</P>
<P>Many cooling methods are available, ranging from expensive device-controlled methods to very cheap cold fluids and ice packs. Proof of superiority of any cooling method above others is still lacking.</P>
<P>After publication of the two RCTs on therapeutic hypothermia (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>), guidelines were published by the International Liaison Committee on Resuscitation (ILCOR) on the application of therapeutic hypothermia after cardiac arrest (<LINK REF="REF-Nolan-2003" TYPE="REFERENCE">Nolan 2003</LINK>). The publication of the Targeted Temperature Management (TTM) trial (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) has led to ongoing discussion about optimal levels of target temperature. In their most recent statement, ILCOR members have advised that "Pending formal consensus on the optimal temperature, we suggest that clinicians provide post-resuscitation care based on the current treatment recommendations. We accept that some clinicians may make a local decision to use a target temperature of 36°C pending this further guidance." Similar up-to-date guidelines of the European Resuscitation Council state the following: "Targeted temperature management remains important but there is now an option to target a temperature of 36°C instead of the previously recommended 32 to 34°C" (<LINK REF="REF-Soar-2015" TYPE="REFERENCE">Soar 2015</LINK>), and the American Heart Association provides this advice: "We recommend selecting and maintaining a constant target temperature between 32°C and 36°C for those patients in whom temperature control is used (strong recommendation, moderate quality evidence)" (<LINK REF="REF-Callaway-2015" TYPE="REFERENCE">Callaway 2015</LINK>).</P>
<P>Investigators have observed that pyrexia after the cooling period is associated with increased mortality and unfavourable neurological outcome (<LINK REF="REF-Bro_x002d_Jeppesen-2013" TYPE="REFERENCE">Bro-Jeppesen 2013</LINK>; <LINK REF="REF-Leary-2013" TYPE="REFERENCE">Leary 2013</LINK>; <LINK REF="REF-Zeiner-2001" TYPE="REFERENCE">Zeiner 2001</LINK>). Mean body temperature 12 hours after the start of cooling in the 'normothermia group' was around 37.6°C in <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> and 37.4°C in <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>. <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK> did not report the body temperature of the control group. Adding results of <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> slightly reduced the effect size, but 33°C in comparison with higher temperatures still showed a significant and relevant beneficial effect for neurological outcome. A dose-response effect over different levels of hypothermia is possible, but studies are still too few to prove this.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Risk of bias was low for most studies and when present did not strongly influence the estimates. Therefore, we considered the results robust against risk of bias from within the studies, and this was confirmed by our sensitivity analysis.</P>
<P>We downgraded the quality of evidence to moderate for main outcomes, mainly as the result of imprecision, as the number of events fell below the limit of the suggested optimal information size (<LINK REF="REF-Guyatt-2011" TYPE="REFERENCE">Guyatt 2011</LINK>).</P>
<P>We graded indirectness as not relevant for the main analysis of our review because it reflects common practice. Furthermore, 90% (in <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>) and 92% (in <LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>) of all eligible participants were randomly assigned. In <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK> and <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>, inclusion of all eligible participants was reported. Generally, participants within the included studies appeared to be treated according to international guidelines. Indirectness,however, was an issue for the analysis of adverse events, for which we pooled all available studies regardless of differences in intervention and control group treatments.</P>
<P>The included studies represent a mixture of efficacy studies and one larger pragmatic study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>). All studies were academia initiated.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>One of the problems involved with merging the data for this review was the difference in inclusion criteria. Generally, among all participants resuscitated and brought to hospital, between 18% and 42% have non-witnessed arrests, only 30% to 58% have a confirmed ventricular fibrillation (VF) rhythm as first rhythm (<LINK REF="REF-Haukoos-2004" TYPE="REFERENCE">Haukoos 2004</LINK>; <LINK REF="REF-Herlitz-2003a" TYPE="REFERENCE">Herlitz 2003a</LINK>; <LINK REF="REF-Kim-2001" TYPE="REFERENCE">Kim 2001</LINK>) and 40% are resuscitated in-hospital. In this review, the two larger studies with available IPD included only participants with a cardiac cause of cardiac arrest, and with VF or ventricular tachycardia (VT) rhythm as the first cardiac rhythm (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>). Most participants had an out-of-hospital cardiac arrest. From the pathogenesis of global cerebral ischaemias and theories as to why therapeutic hypothermia is effective, we could find no reason why therapeutic hypothermia should not be as effective in participants with asystole as the first cardiac rhythm or in those with non-cardiac causes for cardiac arrest. In a meta-analysis (<LINK REF="REF-Holzer-2005" TYPE="REFERENCE">Holzer 2005</LINK>), the effect of therapeutic hypothermia was only sightly changed by baseline variables. A retrospective cohort study showed that the effect of therapeutic hypothermia was independent of various confounders, including cardiac arrest conditions (<LINK REF="REF-Arrich-2006" TYPE="REFERENCE">Arrich 2006</LINK>).</P>
<P>The trial by <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK> and colleagues was published as an abstract. In personal communications, we were able to receive information about the cooling method but not about quality criteria for this randomized controlled trial. Therefore, we have rated most of the quality criteria in our risk of bias assessment as 'unclear'.</P>
<P>The most recent study (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>) was the largest one in this field of research. Adding these data introduced considerable heterogeneity, which we had not observed with the existing studies. A clinical viewpoint suggests various reasons, the most obvious being the control group, which was kept at 36°C and not 'no cooling' as in other studies. The design of <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> was a pragmatic one (multi-centre, different methods of cooling, etc.), which may not be suitable as long as the cooling 'dose', which is mainly target temperature and cooling duration, is not unequivocally characterized in proof of concept studies. Additionally, <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK> had a very short duration from collapse to resuscitation (one minute) compared with the other trials (around 10 minutes). Reports show that the effect of therapeutic hypothermia depends strongly on this no flow time (<LINK REF="REF-Testori-2012" TYPE="REFERENCE">Testori 2012</LINK>). Knowing whether the results of this study should be added to existing data, especially as they caused a high level of heterogeneity, was challenging. To provide the most informative picture of all levels of hypothermia, we have decided to present an ancillary analysis at the study level. Despite controversial arguments against and for pooling of all studies, a beneficial and statistically significant effect on neurological outcome was seen when all studies on conventional cooling were pooled (RR 1.53, 95% CI 1.02 to 2.29).</P>
<P>For the subgroup of participants with non-witnessed arrests, we observed an effect size substantially greater than the pooled summary effect (RR 5.31, 95% CI 1.40 to 20.21) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). However, the group of non-witnessed arrests was small (22 participants only) and yielded large confidence intervals. Although it seems that participants benefited from the treatment provided, the result should be interpreted with caution.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We are aware of three other meta-analyses with similar objectives. The meta-analysis by <LINK REF="REF-Holzer-2005" TYPE="REFERENCE">Holzer 2005</LINK> is very similar to the one performed in our review method-wise and in many ways was a predecessor to the first version of this Cochrane review. We were able to include two additional studies (<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK>; <LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>), but the main result is comparable. Another meta-analysis was published in 2011 (<LINK REF="REF-Nielsen-2011" TYPE="REFERENCE">Nielsen 2011</LINK>). The review authors judged the overall quality of the included studies to be at a lower level than we did in our review. From the available five studies, they combined four and five on the basis of a different judgement on clinical heterogeneity, and they provided a trial sequential analysis. The main findings were comparable between the two reviews, whereas their interpretation was more conservative than ours. We found a third meta-analysis published recently, which focused on the safety effects of therapeutic hypothermia (<LINK REF="REF-Xiao-2013" TYPE="REFERENCE">Xiao 2013</LINK>). Upon pooling randomized and non-randomized studies, review authors found overall better survival with therapeutic hypothermia with a slightly elevated incidence of arrhythmia and hypokalaemia.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<IMPLICATIONS_PRACTICE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Moderate-quality evidence suggests that conventional cooling methods to induce mild therapeutic hypothermia improve neurological outcome after cardiac arrest, specifically if compared with no temperature management. Available evidence was derived from studies in which the target temperature was 34°C or lower. This is in line with current best medical practice as recommended by international resuscitation guidelines (<LINK REF="REF-Callaway-2015" TYPE="REFERENCE">Callaway 2015</LINK>; <LINK REF="REF-Soar-2015" TYPE="REFERENCE">Soar 2015</LINK>) on using hypothermia/targeted temperature management for survivors of cardiac arrest. We had insufficient evidence to determine the effects of therapeutic hypothermia on participants with in-hospital cardiac arrest, asystole or non-cardiac causes of arrest<I>.</I>
</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>A considerable knowledge gap for what constitutes an optimal cooling protocol is ongoing. Available clinical trials on therapeutic hypothermia comprise a variety of patient populations and modes of hypothermia. It remains specifically unclear what the ideal target temperature should be. Likewise, it is unclear for what period of time targeted temperature management should be maintained. Whether cooling should be initiated prehospital or in-hospital needs further research. We expect that mild therapeutic hypothermia exerts its effects differently across subgroups of participants, but evidence is lacking. Evaluation of a possible dose-response effect of therapeutic hypothermia would shed some light on an optimal treatment regimen with ample room for cost-effectiveness analyses.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>We would like to thank the editorial team and the peer reviewers of this updated review 2015 (Vibeke E Horstmann, Sheila Page, Rodrigo Cavallazzi and Jane Cracknell).</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Jasmin Arrich has no conflicts of interest.</P>
<P>
<BR/>Michael Holzer received travel grants for scientific conferences and honoraria for lectures from Bard Medical, EmCools, Polimed Sp. z o.o. and Zoll Medical Österreich. He received honoraria for consulting from Zoll Medical Österreich and was responsible for studies for which the Department of Emergency Medicine received study grants from Velomedix and Philips.</P>
<P>Marcus Müllner, Michael Holzer and Christof Havel were involved in the design, conduct and publication of the <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> trial. None of the authors of the <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> trial extracted data from that trial.</P>
<P>Harald Herkner has no conflicts of interest.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Conceiving of review and update: Harald Herkner (HH), Michael Holzer (MH), Marcus Müllner (MM), Christof Havel (CH).<BR/>Co-ordinating the review: HH, Jasmin Arrich (JA).<BR/>Undertaking manual searches: MH, JA.<BR/>Screening search results: MH, JA, CH.<BR/>Organizing retrieval of papers: JA.<BR/>Screening retrieved papers against inclusion criteria: MH, JA, MM, CH.<BR/>Appraising quality of papers: MH, HH, JA, MM, CH.<BR/>Abstracting data from papers: MH, JA, CH.<BR/>Writing to authors of papers for additional information: MH, JA.<BR/>Providing additional data about papers: MH, JA.<BR/>Obtaining and screening data on unpublished studies: MH, JA.<BR/>Managing data for the review: HH, JA, MM.<BR/>Entering data into Review Manager (<LINK REF="REF-RevMan-5.3" TYPE="REFERENCE">RevMan 5.3</LINK>): MH, JA.<BR/>Analysing RevMan statistical data: HH, MM, JA.<BR/>Performing other statistical analyses not using RevMan: HH, MM.<BR/>Performing double entry of data: MH, JA.<BR/>Interpreting data: MH, HH, JA, MM, CH.<BR/>Making statistical inferences: HH, MM, JA.<BR/>Writing the review: JA, MM, HH.<BR/>Securing funding for the review: not applicable.<BR/>Performing previous work that served as the foundation of the present study: MM, MH, CH.<BR/>Serving as guarantor for the review (one review author): JA.<BR/>Taking responsibility for reading and checking the review before submission: HH.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<SUBSECTION>
<HEADING LEVEL="2">Update 2015</HEADING>
<P>We did not search the PASCAL database, as it was no longer available at our institution. We additionally searched three trial registers (<A HREF="https://eudract.ema.europa.eu/">EudraCT</A>, <A HREF="http://ClinicalTrials.gov">ClinicalTrials.gov</A> and the <A HREF="http://www.who.int/ictrp/">International Clinical Trials Registry Platform</A>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Update 2012 (Arrich 2012)</HEADING>
<P>In our protocol (<LINK REF="REF-Arrich-2003" TYPE="REFERENCE">Arrich 2003</LINK>), we aimed to include additional endpoints such as six-month and final CPC scores, long-term mortality, quality of life at six months, long-term dependency and cost-effectiveness. Retrieved studies provided no information on long-term mortality, quality of life or cost-effectiveness.</P>
<P>All studies included in the individual patient analysis provided data on both best and final neurological outcome (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>; <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK>; <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK>). In our opinion, the 'best neurological score during hospital stay' is superior to the final score, as the final score may be influenced by other factors such as worsening of body functions or re-arrests.</P>
<P>
<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK> and <LINK REF="STD-Hachimi_x002d_Idrissi-2001" TYPE="STUDY">Hachimi-Idrissi 2001</LINK> provided information on survival to hospital discharge, <LINK REF="STD-HACA-2002" TYPE="STUDY">HACA 2002</LINK> additionally on six-month survival and <LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK> only on six-month survival. As the study by Laurent was not included in individual patient analyses, we chose survival to hospital discharge as a secondary endpoint for the individual patient analysis.</P>
<P>Documentation of adverse effects was overlooked in the original protocol. As they form a vital part of every review, we included adverse effects on the data extraction sheet before we performed the literature search.</P>
<P>In accordance with our reviewers, to better explain the reasons for dual analysis and the way it was carried out, we have changed the wording of the objectives from</P>
<P>"The aim of this study is to present a systematic review of the literature and, if applicable, a meta-analysis, concerning the neuroprotective effect of induced hypothermia in primary cardiac arrest survivors. We plan to use data at the aggregate (study) level and the individual (patient) level."</P>
<P>to</P>
<P>"We aimed to perform a systematic review and meta-analysis to assess the effectiveness of therapeutic hypothermia in participants after cardiac arrest. neurological outcome, survival and adverse events were our main outcomes. We aimed to perform individual patient data analysis if data were available. We intended to form subgroups according to the cardiac arrest situation."</P>
<P>The title has been changed from "Hypothermia for neuroprotection after cardiopulmonary resuscitation" to "Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation".</P>
</SUBSECTION>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>May 2015: We adopted the GRADE approach for our review.</P>
<P>We would like to thank Dr Mathew Zacharias (Content Editor), Dr Marialena Trivella (Statistical Editor) and Dr Malcolm G Booth, Dr George Djaiani and Shafi Mussa (Peer Reviewers) for help and editorial advice provided during preparation of the earlier version of this review (<LINK REF="REF-Arrich-2009" TYPE="REFERENCE">Arrich 2009</LINK>).</P>
<P>We would also like to thank Dr Mathew Zacharias, Dr Marialena Trivella, Dr Malcolm Booth, Dr Karen Rees, Prof Ian Jacobs and Jane Cracknell for help and editorial advice provided during preparation of the protocol (<LINK REF="REF-Arrich-2003" TYPE="REFERENCE">Arrich 2003</LINK>) for the systematic review.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<INCLUDED_STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<STUDY DATA_SOURCE="PUB" ID="STD-Bernard-2002" MODIFIED="2009-08-10 20:58:38 +0100" MODIFIED_BY="Jane Cracknell" NAME="Bernard 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-08-10 20:58:38 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, et al</AU>
<TI>Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>8</NO>
<PG>557-63</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:32:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:32:44 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11856794"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-HACA-2002" MODIFIED="2012-07-22 11:34:16 +0100" MODIFIED_BY="[Empty name]" NAME="HACA 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-08-10 20:58:38 +0100" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hypothermia after Cardiac Arrest Study Group</AU>
<TI>Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest</TI>
<SO>New England Journal of Medicine</SO>
<YR>2002</YR>
<VL>346</VL>
<NO>8</NO>
<PG>549-56</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11856793"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-22 11:33:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Kovala TT, Takkunen OS, Roine RO</AU>
<TI>Somatosensory and brainstem auditory evoked potentials in cardiac arrest patients treated with hypothermia</TI>
<SO>Critical Care Medicine</SO>
<YR>2005</YR>
<VL>33</VL>
<NO>8</NO>
<PG>1736-40</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="16096450"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-22 11:33:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Poutiainen E, Kovala T, Takkunen O, Happola O, Roine RO</AU>
<TI>Cognitive and neurophysiological outcome of cardiac arrest survivors treated with therapeutic hypothermia</TI>
<SO>Stroke</SO>
<YR>2007</YR>
<VL>38</VL>
<NO>8</NO>
<PG>2303-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="17585081"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-22 11:34:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Roine RO, Pettila V, Takkunen O</AU>
<TI>Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia</TI>
<SO>Stroke</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>12</NO>
<PG>2881-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="14631087"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Hachimi_x002d_Idrissi-2001" MODIFIED="2012-01-03 10:41:30 +0000" MODIFIED_BY="[Empty name]" NAME="Hachimi-Idrissi 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L</AU>
<TI>Mild hypothermia induced by a helmet device: a clinical feasibility study</TI>
<SO>Resuscitation</SO>
<YR>2001</YR>
<VL>51</VL>
<NO>3</NO>
<PG>275-81</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="11738778"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurent-2005" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Laurent 2005" YEAR="2005">
<REFERENCE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, et al</AU>
<TI>High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2005</YR>
<VL>46</VL>
<NO>3</NO>
<PG>432-7</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="16053954"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mori-2000" MODIFIED="2012-07-22 11:54:12 +0100" MODIFIED_BY="[Empty name]" NAME="Mori 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-07-22 11:54:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Mori K, Takeyama Y, Itoh Y, Nara S, Yoshida M, Ura H, et al</AU>
<TI>A multivariate analysis of prognostic factors in survivors of out-of-hospital cardiac arrest with brain hypothermia</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<PG>A168</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nielsen-2013" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Nielsen 2013" YEAR="2013, 2013">
<REFERENCE MODIFIED="2015-04-19 09:37:05 +0100" MODIFIED_BY="Jasmin " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>CAEP/ACMU</AU>
<TI>2013 CAEP/ACMU Scientific Abstracts, CAEP 2013 June 1&#8211;5, 2013, Vancouver, British Columbia</TI>
<SO>Canadian Journal of Emergency Medicine</SO>
<YR>2013</YR>
<VL>15</VL>
<PG>S1-S79</PG>
<IDENTIFIERS>
<IDENTIFIER OTHERTYPE="Embase/Ovid Accession Number" TYPE="OTHER" VALUE="75003618"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al; TTM Trial Investigators</AU>
<TI>Targeted temperature management at 33°C versus 36°C after cardiac arrest</TI>
<SO>New England Journal of Medicine</SO>
<YR>2013</YR>
<VL>369</VL>
<NO>23</NO>
<PG>2197-206</PG>
<IDENTIFIERS MODIFIED="2015-03-09 20:38:19 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-03-09 20:38:13 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24237006"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-12-29 08:50:17 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2014-12-29 08:50:17 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-10-21 14:14:21 +0100" MODIFIED_BY="Jasmin ">
<STUDY DATA_SOURCE="PUB" ID="STD-CAEP_x002f_ACMU-2013" MODIFIED="2015-04-18 18:41:05 +0100" MODIFIED_BY="Jasmin " NAME="CAEP/ACMU 2013" YEAR="">
<REFERENCE MODIFIED="2015-04-18 18:41:05 +0100" MODIFIED_BY="Jasmin " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>CAEP/ACMU</AU>
<TI>2013 CAEP/ACMU Scientific Abstracts, CAEP 2013 June 1&#8211;5, 2013, Vancouver, British Columbia</TI>
<SO>Canadian Journal of Emergency Medicine</SO>
<YR>2013</YR>
<VL>15</VL>
<PG>S1-S79</PG>
<IDENTIFIERS MODIFIED="2015-03-11 13:11:16 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-03-11 13:11:16 +0000" MODIFIED_BY="[Empty name]" OTHERTYPE="Embase/Ovid Accession Number" TYPE="OTHER" VALUE="75003618"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopez_x002d_de_x002d_Sa-2012" MODIFIED="2015-01-01 21:15:58 +0000" MODIFIED_BY="[Empty name]" NAME="Lopez-de-Sa 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-01-01 21:15:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopez-de-Sa E, Rey JR, Armada E, Salinas P, Viana-Tejedor A, Espinosa-Garcia S, et al</AU>
<TI>Hypothermia in comatose survivors from out-of-hospital cardiac arrest: pilot trial comparing 2 levels of target temperature</TI>
<SO>Circulation</SO>
<YR>2012</YR>
<VL>126</VL>
<NO>24</NO>
<PG>2826-33</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="23136160"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takeda-2009" MODIFIED="2015-03-31 11:36:23 +0100" MODIFIED_BY="Jasmin " NAME="Takeda 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-03-31 11:36:23 +0100" MODIFIED_BY="Jasmin " PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takeda Y, Kawashima T, Kiyota K, Oda S, Morimoto N, Kobata H, et al</AU>
<TI>Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency room</TI>
<SO>Resuscitation</SO>
<YR>2014</YR>
<VL>85</VL>
<NO>12</NO>
<PG>1647-53</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="25263513"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-22 11:50:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Takeda Y, Shiraishi K, Naito H, Hagioka S, Morimoto N, Morita K</AU>
<TI>A randomized controlled trial of pharyngeal cooling system during cardiopulmonary resuscitation</TI>
<SO>Journal of Neurosurgical Anesthesiology</SO>
<YR>2009</YR>
<VL>21</VL>
<NO>4</NO>
<PG>407-8</PG>
<IDENTIFIERS MODIFIED="2011-12-01 15:22:38 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-01 15:22:31 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="http://dx.doi.org/10.1097/01.ana.0000358102.35410.08"/>
<IDENTIFIER MODIFIED="2011-12-01 15:22:14 +0000" MODIFIED_BY="[Empty name]" TYPE="EMBASE" VALUE="70034508"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-11-11 13:56:16 +0000" MODIFIED_BY="Jasmin "/>
<ONGOING_STUDIES MODIFIED="2015-11-23 20:22:32 +0000" MODIFIED_BY="Jasmin "/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<ADDITIONAL_REFERENCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Absalom-1999" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Absalom 1999" TYPE="JOURNAL_ARTICLE">
<AU>Absalom AR, Bradley P, Soar J</AU>
<TI>Out-of-hospital cardiac arrests in an urban/rural area during 1991 and 1996: have emergency medical service changes improved outcome?</TI>
<SO>Resuscitation</SO>
<YR>1999</YR>
<VL>40</VL>
<PG>3-9</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:33:06 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:33:06 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10321842"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arrich-2006" MODIFIED="2015-03-25 10:27:34 +0000" MODIFIED_BY="[Empty name]" NAME="Arrich 2006" TYPE="JOURNAL_ARTICLE">
<AU>Arrich J, Sterz F, Fleischhackl R, Uray T, Losert H, Kliegel A, et al</AU>
<TI>Gender modifies the influence of age on outcome after successfully resuscitated cardiac arrest: a retrospective cohort study</TI>
<SO>Medicine</SO>
<YR>2006</YR>
<VL>85</VL>
<NO>5</NO>
<PG>288-94</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:36:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:36:02 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="16974213 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Baumann-2009" MODIFIED="2012-07-22 11:55:38 +0100" MODIFIED_BY="[Empty name]" NAME="Baumann 2009" TYPE="JOURNAL_ARTICLE">
<AU>Baumann E, Preston E, Slinn J, Stanimirovic D</AU>
<TI>Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia</TI>
<SO>Brain Research</SO>
<YR>2009</YR>
<VL>1269</VL>
<PG>185-97</PG>
<IDENTIFIERS MODIFIED="2012-06-02 18:58:19 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19285050"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bro_x002d_Jeppesen-2013" MODIFIED="2015-01-27 11:27:59 +0000" MODIFIED_BY="[Empty name]" NAME="Bro-Jeppesen 2013" TYPE="JOURNAL_ARTICLE">
<AU>Bro-Jeppesen J, Hassager C, Wanscher M, Soholm H, Thomsen JH, Lippert FK, et al</AU>
<TI>Post-hypothermia fever is associated with increased mortality after out-of-hospital cardiac arrest</TI>
<SO>Resuscitation</SO>
<YR>2013</YR>
<VL>84</VL>
<NO>12</NO>
<PG>1734-40</PG>
<IDENTIFIERS MODIFIED="2015-01-27 11:27:57 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23917079"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-B_x00f6_ttiger-1999" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Böttiger 1999" TYPE="JOURNAL_ARTICLE">
<AU>Böttiger BW, Grabner C, Bauer H, Bode C, Weber T, Motsch J, et al</AU>
<TI>Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban/suburban area</TI>
<SO>Heart</SO>
<YR>1999</YR>
<VL>82</VL>
<PG>674-9</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:40:04 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:40:04 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10573491"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Callaway-2015" MODIFIED="2015-11-09 13:03:25 +0000" MODIFIED_BY="Jasmin " NAME="Callaway 2015" TYPE="JOURNAL_ARTICLE">
<AU>Callaway CW, Soar J, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, et al</AU>
<TI>Part 4: Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations</TI>
<SO>Circulation</SO>
<YR>2015</YR>
<VL>132</VL>
<NO>16 Suppl 1</NO>
<PG>S84-S145</PG>
<IDENTIFIERS MODIFIED="2015-11-09 13:03:23 +0000" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="26472860"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cheung-2006" MODIFIED="2009-07-23 11:50:03 +0100" MODIFIED_BY="Jane Cracknell" NAME="Cheung 2006" TYPE="JOURNAL_ARTICLE">
<AU>Cheung KW, Green RS, Magee KD</AU>
<TI>Systematic review of randomized controlled trials of therapeutic hypothermia as a neuroprotectant in post cardiac arrest patients</TI>
<SO>Canadian Journal of Emergency Medical Care</SO>
<YR>2006</YR>
<VL>8</VL>
<NO>5</NO>
<PG>329-37</PG>
<IDENTIFIERS MODIFIED="2009-07-23 11:49:28 +0100" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2009-07-23 11:49:28 +0100" MODIFIED_BY="Jane Cracknell" TYPE="MEDLINE" VALUE=" 17338844"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chugh-2004" MODIFIED="2011-07-03 18:52:12 +0100" MODIFIED_BY="[Empty name]" NAME="Chugh 2004" TYPE="JOURNAL_ARTICLE">
<AU>Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, et al</AU>
<TI>Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>2004</YR>
<VL>44</VL>
<NO>6</NO>
<PG>1268-75</PG>
<IDENTIFIERS MODIFIED="2011-07-03 18:52:10 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15364331"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-D_x0027_Cruz-2002" MODIFIED="2012-07-22 11:56:30 +0100" MODIFIED_BY="[Empty name]" NAME="D'Cruz 2002" TYPE="JOURNAL_ARTICLE">
<AU>D'Cruz BJ, Fertig KC, Filiano AJ, Hicks SD, DeFranco DB, Callaway CW</AU>
<TI>Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation</TI>
<SO>Journal of Cerebral Blood Flow and Metabolism</SO>
<YR>2002</YR>
<VL>22</VL>
<NO>7</NO>
<PG>843-51</PG>
<IDENTIFIERS MODIFIED="2012-05-29 20:31:08 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12142569"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deakin-2010" MODIFIED="2015-11-20 13:07:53 +0000" MODIFIED_BY="Jasmin " NAME="Deakin 2010" TYPE="JOURNAL_ARTICLE">
<AU>Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, et al</AU>
<TI>European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support</TI>
<SO>Resuscitation</SO>
<YR>2010</YR>
<VL>81</VL>
<NO>10</NO>
<PG>1305-52</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="20956049"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>629-34</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="9310563"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Finn-2001" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Finn 2001" TYPE="JOURNAL_ARTICLE">
<AU>Finn JC, Jacobs IG, Holman CD, Oxer HF</AU>
<TI>Outcomes of out-of-hospital cardiac arrest patients in Perth, Western Australia, 1996-1999</TI>
<SO>Resuscitation</SO>
<YR>2001</YR>
<VL>51</VL>
<PG>247-55</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:46:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:46:11 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11738774"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fischer-1997" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Fischer 1997" TYPE="JOURNAL_ARTICLE">
<AU>Fischer M, Fischer NJ, Schuttler J</AU>
<TI>One-year survival after out-of-hospital cardiac arrest in Bonn city: outcome report according to the 'Utstein style'</TI>
<SO>Resuscitation</SO>
<YR>1997</YR>
<VL>33</VL>
<PG>233-43</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:46:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:46:42 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9044496"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fourth-Framework-Programme" MODIFIED="2015-05-09 09:42:26 +0100" MODIFIED_BY="Jasmin " NAME="Fourth Framework Programme" TYPE="OTHER">
<TI>The Fourth Framework Programme</TI>
<SO>The European Commission [updated May 2001]. http://ec.europa.eu/research/fp4.html. (accessed [09/05/2015])</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FWF" MODIFIED="2015-12-01 10:16:33 +0000" MODIFIED_BY="Jane Cracknell" NAME="FWF" TYPE="OTHER">
<TI>Austrian Science Foundation (FWF)</TI>
<SO>Available from www.fwf.ac.at/en/ (accessed April 2015)</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-GAMBRO" MODIFIED="2015-12-01 10:17:50 +0000" MODIFIED_BY="Jane Cracknell" NAME="GAMBRO" TYPE="OTHER">
<TI>Gambro Hospal Austria GmbH</TI>
<SO>Available from www.gambro.at (accessed May 2015)</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Giraud-1996" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Giraud 1996" TYPE="JOURNAL_ARTICLE">
<AU>Giraud F, Rascle C, Guignand M</AU>
<TI>Out-of-hospital cardiac arrest. Evaluation of one year of activity in Saint-Etienne's emergency medical system using the Utstein style</TI>
<SO>Resuscitation</SO>
<YR>1996</YR>
<VL>33</VL>
<PG>19-27</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:47:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:47:29 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8959769"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEPRO" MODIFIED="2015-05-06 10:45:07 +0100" MODIFIED_BY="Jasmin " NAME="GRADEPRO" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro. [Computer program on www.gradepro.org]. Version [6th of May 2015]</TI>
<YR>2014</YR>
<PB>McMaster University</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011" MODIFIED="2015-11-17 20:41:19 +0000" MODIFIED_BY="Jasmin " NAME="Guyatt 2011" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al</AU>
<TI>GRADE guidelines 6. Rating the quality of evidence--imprecision</TI>
<SO>Journal of clinical epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1283-93</PG>
<IDENTIFIERS MODIFIED="2015-11-17 20:41:16 +0000" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="21839614"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hachimi_x002d_Idrissi-2004" MODIFIED="2012-07-22 11:57:36 +0100" MODIFIED_BY="[Empty name]" NAME="Hachimi-Idrissi 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hachimi-Idrissi S, Van Hemelrijck A, Michotte A, Smolders I, Sarre S, Ebinger G, et al</AU>
<TI>Postischemic mild hypothermia reduces neurotransmitter release and astroglial cell proliferation during reperfusion after asphyxial cardiac arrest in rats</TI>
<SO>Brain Research</SO>
<YR>2004</YR>
<VL>1019</VL>
<NO>1-2</NO>
<PG>217-25</PG>
<IDENTIFIERS MODIFIED="2012-05-29 20:29:52 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15306256"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haukoos-2004" MODIFIED="2008-07-12 09:20:22 +0100" MODIFIED_BY="[Empty name]" NAME="Haukoos 2004" TYPE="JOURNAL_ARTICLE">
<AU>Haukoos JS, Lewis RJ, Niemann JT</AU>
<TI>Prediction rules for estimating neurologic outcome following out-of-hospital cardiac arrest</TI>
<SO>Resuscitation</SO>
<YR>2004</YR>
<VL>63</VL>
<PG>145-55</PG>
<IDENTIFIERS MODIFIED="2008-07-12 09:20:21 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="15531065"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herlitz-1999" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Herlitz 1999" TYPE="JOURNAL_ARTICLE">
<AU>Herlitz J, Bahr J, Fischer M, Kuisma M, Lexow K, Thorgeirsson G</AU>
<TI>Resuscitation in Europe: a tale of five European regions</TI>
<SO>Resuscitation</SO>
<YR>1999</YR>
<VL>41</VL>
<PG>121-31</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:48:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:48:15 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="10488934"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herlitz-2003a" MODIFIED="2008-07-12 09:13:24 +0100" MODIFIED_BY="[Empty name]" NAME="Herlitz 2003a" TYPE="JOURNAL_ARTICLE">
<AU>Herlitz J, Bang A, Gunnarsson J, Engdahl J, Karlson BW, Lindqvist J, et al</AU>
<TI>Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Goteborg, Sweden</TI>
<SO>Heart</SO>
<YR>2003</YR>
<VL>89</VL>
<NO>1</NO>
<PG>25-30</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:48:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:48:49 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12482785"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herlitz-2003b" MODIFIED="2008-07-12 09:13:36 +0100" MODIFIED_BY="[Empty name]" NAME="Herlitz 2003b" TYPE="JOURNAL_ARTICLE">
<AU>Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S</AU>
<TI>Changes in demographic factors and mortality after out-of-hospital cardiac arrest in Sweden</TI>
<SO>Coronary Artery Disease</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>1</NO>
<PG>51-7</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:49:23 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:49:23 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15654201"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2009-08-10 20:58:38 +0100" MODIFIED_BY="Jane Cracknell" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:50:18 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:50:18 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12958120"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Higgins 2011" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011</SO>
<YR>2011</YR>
<PB>www.cochrane-handbook.org</PB>
<IDENTIFIERS MODIFIED="2015-03-11 13:40:54 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-03-11 13:40:54 +0000" MODIFIED_BY="[Empty name]" OTHERTYPE="ISBN" TYPE="OTHER" VALUE="0727909045"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Holzer-2005" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Holzer 2005" TYPE="JOURNAL_ARTICLE">
<AU>Holzer M, Bernard SA, Hachimi-Idrissi S, Roine RO, Sterz F, Müllner M; on behalf of the Collaborative Group on Induced Hypothermia for Neuroprotection After Cardiac Arrest</AU>
<TI>Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis</TI>
<SO>Critical Care Medicine</SO>
<YR>2005</YR>
<VL>33</VL>
<NO>2</NO>
<PG>414-8</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:53:46 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:53:46 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15699847"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Holzer-2010" MODIFIED="2012-07-22 11:58:27 +0100" MODIFIED_BY="[Empty name]" NAME="Holzer 2010" TYPE="JOURNAL_ARTICLE">
<AU>Holzer M</AU>
<TI>Targeted temperature management for comatose survivors of cardiac arrest</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>363</VL>
<NO>13</NO>
<PG>1256-64</PG>
<IDENTIFIERS MODIFIED="2012-05-29 19:38:40 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20860507"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jennings-2001" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Jennings 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jennings P, Pasco J</AU>
<TI>Survival from out-of-hospital cardiac arrest in the Geelong region of Victoria, Australia</TI>
<SO>Emergency Medicine</SO>
<YR>2001</YR>
<VL>13</VL>
<PG>319-25</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:54:37 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:54:37 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11554863"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Karibe-1994" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Karibe 1994" TYPE="JOURNAL_ARTICLE">
<AU>Karibe H, Zarow GJ, Graham SH, Weinstein PR</AU>
<TI>Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats</TI>
<SO>Journal of Cerebral Blood Flow and Metabolism</SO>
<YR>1994</YR>
<VL>14</VL>
<PG>620-7</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:55:12 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:55:12 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8014209"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kim-2001" MODIFIED="2012-07-22 11:59:17 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kim C, Fahrenbruch CE, Cobb LA, Eisenberg MS</AU>
<TI>Out-of-hospital cardiac arrest in men and women</TI>
<SO>Circulation</SO>
<YR>2001</YR>
<VL>104</VL>
<PG>2699-703</PG>
<IDENTIFIERS MODIFIED="2008-07-12 09:18:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="MEDLINE" VALUE="11723022"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kuisma-1996" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kuisma 1996" TYPE="JOURNAL_ARTICLE">
<AU>Kuisma M, Maatta T</AU>
<TI>Out-of-hospital cardiac arrests in Helsinki: Utstein style reporting</TI>
<SO>Heart</SO>
<YR>1996</YR>
<VL>76</VL>
<PG>18-23</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:56:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:56:14 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8774321"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Langendam-2013" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Langendam 2013" TYPE="JOURNAL_ARTICLE">
<AU>Langendam MW, Akl EA, Dahm P, Glasziou P, Guyatt G, Schünemann HJ</AU>
<TI>Assessing and presenting summaries of evidence in Cochrane Reviews</TI>
<SO>Systematic Reviews</SO>
<YR>2013</YR>
<VL>2</VL>
<PG>81</PG>
<IDENTIFIERS MODIFIED="2015-05-06 10:41:43 +0100" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="24059250"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leary-2013" MODIFIED="2015-01-27 11:27:59 +0000" MODIFIED_BY="[Empty name]" NAME="Leary 2013" TYPE="JOURNAL_ARTICLE">
<AU>Leary M, Grossestreuer AV, Iannacone S, Gonzalez M, Shofer FS, Povey C, et al</AU>
<TI>Pyrexia and neurologic outcomes after therapeutic hypothermia for cardiac arrest</TI>
<SO>Resuscitation</SO>
<YR>2013</YR>
<VL>84</VL>
<NO>8</NO>
<PG>1056-61</PG>
<IDENTIFIERS MODIFIED="2015-01-27 11:27:57 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="23153649"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lee-2010" MODIFIED="2012-07-22 11:59:50 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2010" TYPE="JOURNAL_ARTICLE">
<AU>Lee HC, Chuang HC, Cho DY, Cheng KF, Lin PH, Chen CC</AU>
<TI>Applying cerebral hypothermia and brain oxygen monitoring in treating severe traumatic brain injury</TI>
<SO>World Neurosurgery</SO>
<YR>2010</YR>
<VL>74</VL>
<NO>6</NO>
<PG>654-60</PG>
<IDENTIFIERS MODIFIED="2012-06-01 18:43:05 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21492636"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leung-2001" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Leung 2001" TYPE="JOURNAL_ARTICLE">
<AU>Leung LP, Wong TW, Tong HK, Lo CB, Kan PG</AU>
<TI>Out-of-hospital cardiac arrest in Hong Kong</TI>
<SO>Prehospital Emergency Care</SO>
<YR>2001</YR>
<VL>5</VL>
<PG>308-11</PG>
<IDENTIFIERS MODIFIED="2008-03-07 15:58:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 15:58:15 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11446552"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McCullough-1999" MODIFIED="2012-07-22 12:00:27 +0100" MODIFIED_BY="[Empty name]" NAME="McCullough 1999" TYPE="JOURNAL_ARTICLE">
<AU>McCullough JN, Zhang N, Reich DL, Juvonen TS, Klein JJ, Spielvogel D, et al</AU>
<TI>Cerebral metabolic suppression during hypothermic circulatory arrest in humans</TI>
<SO>The Annals of Thoracic Surgery</SO>
<YR>1999</YR>
<VL>67</VL>
<NO>6</NO>
<PG>1895-9; discussion 1919-21</PG>
<IDENTIFIERS MODIFIED="2012-05-29 20:40:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10391334"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McNally-2011" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="McNally 2011" TYPE="JOURNAL_ARTICLE">
<AU>McNally B, Robb R, Mehta M, Vellano K, Valderrama AL, Yoon PW, et al</AU>
<TI>Out-of-hospital cardiac arrest surveillance --- Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005--December 31, 2010</TI>
<SO>Morbidity and Mortality Weekly Report. Surveillance Summaries</SO>
<YR>2011</YR>
<VL>60</VL>
<NO>8</NO>
<PG>1-19</PG>
<IDENTIFIERS MODIFIED="2015-03-09 10:53:42 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21796098"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mizuhara-1996" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Mizuhara 1996" TYPE="JOURNAL_ARTICLE">
<AU>Mizuhara A</AU>
<TI>[The protective effect of hypothermia in a new transient cerebral ischemic model of the rat--A 31P magnetic resonance spectroscopy in vivo study]</TI>
<SO>Nippon Kyobu Geka Gakkai Zasshi</SO>
<YR>1996</YR>
<VL>44</VL>
<PG>1-8</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:35:49 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:35:49 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8683162 "/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Negovsky-1988" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Negovsky 1988" TYPE="JOURNAL_ARTICLE">
<AU>Negovsky VA</AU>
<TI>Postresuscitation disease</TI>
<SO>Critical Care Medicine</SO>
<YR>1988</YR>
<VL>16</VL>
<PG>942-6</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:37:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:37:03 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="3048895"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nielsen-2011" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Nielsen 2011" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen N, Friberg H, Gluud C, Herlitz J, Wetterslev J</AU>
<TI>Hypothermia after cardiac arrest should be further evaluated - a systematic review of randomised trials with meta-analysis and trial sequential analysis</TI>
<SO>International Journal of Cardiology</SO>
<YR>2011</YR>
<VL>151</VL>
<NO>3</NO>
<PG>333-41</PG>
<IDENTIFIERS MODIFIED="2012-04-24 11:36:33 +0100" MODIFIED_BY="Harald Herkner">
<IDENTIFIER TYPE="PUBMED" VALUE="20591514"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nolan-2003" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Nolan 2003" TYPE="JOURNAL_ARTICLE">
<AU>Nolan JP, Morley PT, Hoek TL, Hickey RW; Advancement Life Support Task Force of the International Liaison Committee on Resuscitation</AU>
<TI>Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life Support Task Force of the International Liaison Committee on Resuscitation</TI>
<SO>Resuscitation</SO>
<YR>2003</YR>
<VL>57</VL>
<NO>3</NO>
<PG>231-5</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:37:30 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:37:30 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="12858857"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Okuda-1986" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Okuda 1986" TYPE="JOURNAL_ARTICLE">
<AU>Okuda C, Saito A, Miyazaki M, Kuriyama K</AU>
<TI>Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia</TI>
<SO>Pharmacology, Biochemistry and Behaviour</SO>
<YR>1986</YR>
<VL>24</VL>
<PG>79-83</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:38:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:38:13 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="2418447"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Peberdy-2010" MODIFIED="2015-11-20 13:07:53 +0000" MODIFIED_BY="Jasmin " NAME="Peberdy 2010" TYPE="JOURNAL_ARTICLE">
<AU>Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zimmerman JL, Donnino M, et al</AU>
<TI>Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care</TI>
<SO>Circulation</SO>
<YR>2010</YR>
<VL>122 Suppl 3</VL>
<NO>18</NO>
<PG>768-86</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="20956225"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rea-2004" MODIFIED="2012-07-22 12:02:17 +0100" MODIFIED_BY="[Empty name]" NAME="Rea 2004" TYPE="JOURNAL_ARTICLE">
<AU>Rea TD, Pearce RM, Raghunathan TE, Lemaitre RN, Sotoodehnia N, Jouven X, et al</AU>
<TI>Incidence of out-of-hospital cardiac arrest</TI>
<SO>The American Journal of Cardiology</SO>
<YR>2004</YR>
<VL>93</VL>
<NO>12</NO>
<PG>1455-60</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:38:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:38:39 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="15194012"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-5.3" MODIFIED="2014-12-29 09:18:43 +0000" MODIFIED_BY="[Empty name]" NAME="RevMan 5.3" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rewers-2000" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Rewers 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rewers M, Tilgreen RE, Crawford ME, Hjortso N</AU>
<TI>One-year survival after out-of-hospital cardiac arrest in Copenhagen according to the 'Utstein style'</TI>
<SO>Resuscitation</SO>
<YR>2000</YR>
<VL>47</VL>
<PG>137-46</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:39:21 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:39:21 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11008151"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rosomoff-1954" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Rosomoff 1954" TYPE="JOURNAL_ARTICLE">
<AU>Rosomoff H, Holaday D</AU>
<TI>Cerebral blood flow and cerebral oxygen consumption during hypothermia</TI>
<SO>American Journal of Physiology</SO>
<YR>1954</YR>
<VL>179</VL>
<PG>85-8</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:39:45 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:39:45 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="13207391"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schreckinger-2009" MODIFIED="2012-07-22 12:02:46 +0100" MODIFIED_BY="[Empty name]" NAME="Schreckinger 2009" TYPE="JOURNAL_ARTICLE">
<AU>Schreckinger M, Marion DW</AU>
<TI>Contemporary management of traumatic intracranial hypertension: is there a role for therapeutic hypothermia?</TI>
<SO>Neurocritical Care</SO>
<YR>2009</YR>
<VL>11</VL>
<NO>3</NO>
<PG>427-36</PG>
<IDENTIFIERS MODIFIED="2012-06-01 18:47:00 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19644773"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Soar-2015" MODIFIED="2015-11-09 13:02:01 +0000" MODIFIED_BY="Jasmin " NAME="Soar 2015" TYPE="JOURNAL_ARTICLE">
<AU>Soar J, Callaway CW, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, et al</AU>
<TI>Part 4: Advanced life support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations</TI>
<SO>Resuscitation</SO>
<YR>2015</YR>
<VL>95</VL>
<PG>e71-e120</PG>
<IDENTIFIERS MODIFIED="2015-11-09 13:00:56 +0000" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="26477429"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stiell-2009" MODIFIED="2012-07-22 12:03:15 +0100" MODIFIED_BY="[Empty name]" NAME="Stiell 2009" TYPE="JOURNAL_ARTICLE">
<AU>Stiell IG, Nesbitt LP, Nichol G, Maloney J, Dreyer J, Beaudoin T, et al</AU>
<TI>Comparison of the Cerebral Performance Category score and the Health Utilities Index for survivors of cardiac arrest</TI>
<SO>Annals of Emergency Medicine</SO>
<YR>2009</YR>
<VL>53</VL>
<NO>2</NO>
<PG>241-8</PG>
<IDENTIFIERS MODIFIED="2011-07-03 20:15:15 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18450329"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Storm-2014" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Storm 2014" TYPE="JOURNAL_ARTICLE">
<AU>Storm C</AU>
<TI>The use of hypothermia and outcome post cardiopulmonary resuscitation in 2014</TI>
<SO>Revista Brasileira de Terapia Intensiva</SO>
<YR>2014</YR>
<VL>26</VL>
<NO>2</NO>
<PG>83-5</PG>
<IDENTIFIERS MODIFIED="2015-10-13 12:28:11 +0100" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="25028942"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stub-2014" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Stub 2014" TYPE="OTHER">
<AU>Stub D</AU>
<TI>Targeted temperature management after cardiac arrest</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2014</YR>
<VL>370</VL>
<NO>14</NO>
<PG>1358</PG>
<IDENTIFIERS MODIFIED="2015-10-13 12:29:16 +0100" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="24693905"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Sun-2010" MODIFIED="2012-07-22 12:03:35 +0100" MODIFIED_BY="[Empty name]" NAME="Sun 2010" TYPE="JOURNAL_ARTICLE">
<AU>Sun S, Tang W, Song F, Yu T, Ristagno G, Shan Y, et al</AU>
<TI>The effects of epinephrine on outcomes of normothermic and therapeutic hypothermic cardiopulmonary resuscitation</TI>
<SO>Critical Care Medicine</SO>
<YR>2010</YR>
<VL>38</VL>
<NO>11</NO>
<PG>2175-80</PG>
<IDENTIFIERS MODIFIED="2012-05-29 20:21:01 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20693888"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Szelenyi-2012" MODIFIED="2012-07-22 12:03:52 +0100" MODIFIED_BY="[Empty name]" NAME="Szelenyi 2012" TYPE="JOURNAL_ARTICLE">
<AU>Szelenyi M, Laszlo Z, Szabo Z, Kromplak Z, Tischler E, Lakatos M, et al</AU>
<TI>Hypothermia down-regulates the LPS-induced norepinephrine (NE) release in ischaemic human heart cells</TI>
<SO>Brain Research Bulletin</SO>
<YR>2012</YR>
<VL>87</VL>
<NO>1</NO>
<PG>67-73</PG>
<IDENTIFIERS MODIFIED="2012-05-29 19:55:39 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="21963948"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Takasu-1996" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Takasu 1996" TYPE="JOURNAL_ARTICLE">
<AU>Takasu A, Yagi K, Okada Y</AU>
<TI>Effect of mild hypothermia on ischemia-induced release of endothelin-1 in dog brain</TI>
<SO>Resuscitation</SO>
<YR>1996</YR>
<VL>31</VL>
<PG>59-64</PG>
<IDENTIFIERS MODIFIED="2008-03-07 16:40:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 16:40:13 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="8701110"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Testori-2012" MODIFIED="2015-03-25 10:27:50 +0000" MODIFIED_BY="[Empty name]" NAME="Testori 2012" TYPE="JOURNAL_ARTICLE">
<AU>Testori C, Sterz F, Holzer M, Losert H, Arrich J, Herkner H, et al</AU>
<TI>The beneficial effect of mild therapeutic hypothermia depends on the time of complete circulatory standstill in patients with cardiac arrest</TI>
<SO>Resuscitation</SO>
<YR>2012</YR>
<VL>83</VL>
<NO>5</NO>
<PG>596-601</PG>
<IDENTIFIERS MODIFIED="2015-02-24 11:35:48 +0000" MODIFIED_BY="Harald Herkner">
<IDENTIFIER MODIFIED="2015-02-24 11:35:48 +0000" MODIFIED_BY="Harald Herkner" TYPE="PUBMED" VALUE="22138057"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thompson-2001" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Thompson 2001" TYPE="BOOK_SECTION">
<AU>Thompson SG</AU>
<TI>Why sources of heterogeneity in meta-analysis should be investigated</TI>
<SO>Systematic Reviews</SO>
<YR>1995</YR>
<PG>48-63</PG>
<EN>1st</EN>
<ED>Chalmers I and Altman DG</ED>
<PB>BMJ Publishing Group</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tiainen-2003" MODIFIED="2012-07-22 12:04:20 +0100" MODIFIED_BY="[Empty name]" NAME="Tiainen 2003" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Roine RO, Pettila V, Takkunen O</AU>
<TI>Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia</TI>
<SO>Stroke</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>12</NO>
<PG>2881-6</PG>
<IDENTIFIERS MODIFIED="2012-04-08 16:47:01 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14631087"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tiainen-2005" MODIFIED="2012-07-22 12:04:58 +0100" MODIFIED_BY="[Empty name]" NAME="Tiainen 2005" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Kovala TT, Takkunen OS, Roine RO</AU>
<TI>Somatosensory and brainstem auditory evoked potentials in cardiac arrest patients treated with hypothermia</TI>
<SO>Critical Care Medicine</SO>
<YR>2005</YR>
<VL>33</VL>
<NO>8</NO>
<PG>1736-40</PG>
<IDENTIFIERS MODIFIED="2012-04-08 16:48:17 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="16096450"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tiainen-2007" MODIFIED="2012-07-22 12:04:35 +0100" MODIFIED_BY="[Empty name]" NAME="Tiainen 2007" TYPE="JOURNAL_ARTICLE">
<AU>Tiainen M, Poutiainen E, Kovala T, Takkunen O, Happola O, Roine RO</AU>
<TI>Cognitive and neurophysiological outcome of cardiac arrest survivors treated with therapeutic hypothermia</TI>
<SO>Stroke</SO>
<YR>2007</YR>
<VL>38</VL>
<NO>8</NO>
<PG>2303-8</PG>
<IDENTIFIERS MODIFIED="2012-01-11 17:47:33 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2012-01-11 17:47:33 +0000" MODIFIED_BY="Jane Cracknell" TYPE="PUBMED" VALUE="17585081"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Weston-1997" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Weston 1997" TYPE="JOURNAL_ARTICLE">
<AU>Weston CF, Jones SD, Wilson RJ</AU>
<TI>Outcome of out-of-hospital cardiorespiratory arrest in south Glamorgan</TI>
<SO>Resuscitation</SO>
<YR>1997</YR>
<VL>34</VL>
<PG>227-33</PG>
<IDENTIFIERS MODIFIED="2008-03-07 17:00:26 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 17:00:26 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="9178383"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Xiao-2013" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Xiao 2013" TYPE="JOURNAL_ARTICLE">
<AU>Xiao G, Guo Q, Shu M, Xie X, Deng J, Zhu Y, et al</AU>
<TI>Safety profile and outcome of mild therapeutic hypothermia in patients following cardiac arrest: systematic review and meta-analysis</TI>
<SO>Emergency Medicine Journal</SO>
<YR>2013</YR>
<VL>30</VL>
<NO>2</NO>
<PG>91-100</PG>
<IDENTIFIERS MODIFIED="2014-12-29 08:41:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22660549"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Zeiner-2001" MODIFIED="2008-05-30 14:11:47 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Zeiner 2001" TYPE="JOURNAL_ARTICLE">
<AU>Zeiner A, Holzer M, Sterz F, Schorkhuber W, Eisenburger P, Havel C, et al</AU>
<TI>Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2001</YR>
<VL>161</VL>
<NO>16</NO>
<PG>2007-12</PG>
<IDENTIFIERS MODIFIED="2008-03-07 17:01:02 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-03-07 17:01:02 +0000" MODIFIED_BY="[Empty name]" TYPE="MEDLINE" VALUE="11525703"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Arrich-2003" MODIFIED="2015-03-25 10:28:11 +0000" MODIFIED_BY="[Empty name]" NAME="Arrich 2003" TYPE="COCHRANE_PROTOCOL">
<AU>Arrich J, Herkner H, Holzer M, Müllner M</AU>
<TI>Hypothermia for neuroprotection after cardiopulmonary resuscitation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2015-03-12 14:15:51 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2015-03-12 14:15:49 +0000" MODIFIED_BY="Jane Cracknell" TYPE="DOI" VALUE="10.1002/14651858.CD004128"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arrich-2009" MODIFIED="2012-01-11 17:38:35 +0000" MODIFIED_BY="Jane Cracknell" NAME="Arrich 2009" TYPE="COCHRANE_REVIEW">
<AU>Arrich J, Holzer M, Herkner H, Müllner M</AU>
<TI>Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-01-11 17:38:35 +0000" MODIFIED_BY="Jane Cracknell">
<IDENTIFIER MODIFIED="2012-01-11 17:38:35 +0000" MODIFIED_BY="Jane Cracknell" TYPE="DOI" VALUE="10.1002/14651858.CD004128.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Arrich-2012" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Arrich 2012" TYPE="JOURNAL_ARTICLE">
<AU>Arrich J, Holzer M, Havel C, Mullner M, Herkner H</AU>
<TI>Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation</TI>
<SO>The Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<VL>9</VL>
<PG>CD004128</PG>
<IDENTIFIERS MODIFIED="2015-01-01 21:11:10 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="22972067"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<REFERENCE ID="REF-Hachimi_x002d_Idrissi-2005" MODIFIED="2015-11-11 13:53:52 +0000" MODIFIED_BY="Jasmin " NAME="Hachimi-Idrissi 2005" TYPE="JOURNAL_ARTICLE">
<AU>Hachimi-Idrissi S, Zizi M, Nguyen DN, Schiettecate J, Ebinger G, Michotte Y, et al</AU>
<TI>The evolution of serum astroglial S-100 beta protein in patients with cardiac arrest treated with mild hypothermia</TI>
<SO>Resuscitation</SO>
<YR>2005</YR>
<VL>64</VL>
<NO>2</NO>
<PG>187-92</PG>
<IDENTIFIERS MODIFIED="2015-11-11 13:53:50 +0000" MODIFIED_BY="Jasmin ">
<IDENTIFIER TYPE="PUBMED" VALUE="15680528"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lascarrou-2015" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Lascarrou 2015" TYPE="JOURNAL_ARTICLE">
<AU>Lascarrou JB, Meziani F, Le Gouge A, Boulain T, Bousser J, Belliard G, et al</AU>
<TI>Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial</TI>
<SO>Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine</SO>
<YR>2015</YR>
<VL>23</VL>
<PG>26</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="25882712"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wolfrum-2007" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NAME="Wolfrum 2007" TYPE="OTHER">
<AU>Wolfrum S</AU>
<TI>Hypothermia After In-hospital Cardiac Arrest (HACAinhospital)</TI>
<SO>In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US).</SO>
<YR>2015-11-23. https://clinicaltrials.gov/show/NCT00457431: NCT00457431</YR>
<IDENTIFIERS MODIFIED="2015-11-23 20:49:54 +0000" MODIFIED_BY="Jasmin ">
<IDENTIFIER MODIFIED="2015-11-23 20:49:54 +0000" MODIFIED_BY="Jasmin " TYPE="OTHER" VALUE="NCT00457431"/>
</IDENTIFIERS>
</REFERENCE>
</PENDING_REFERENCES>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Bernard-2002">
<CHAR_METHODS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: pre-hospital</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 77, mean age 66 years, 33% female</P>
<P>Out-of-hospital cardiac arrest of cardiac cause, ventricular fibrillation as first cardiac rhythm, comatose after resuscitation</P>
<P>Participating sites: Australian university and community hospitals</P>
<P>Multi-centre: yes</P>
<P>Language: English</P>
<P>Allocation concealment: not applicable (odd and even days)</P>
<P>Outcome assessor blind: yes</P>
<P>Intention-to-treat analysis: yes</P>
<P>Groups comparable: more females and more bystander CPR in hypothermia group</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Therapeutic hypothermia vs standard pre-hospital treatment protocols and intensive care treatment</P>
<P>Means of cooling: ice packs placed around head, neck, torso and limbs</P>
<P>Cooling rate: time from ROSC to target temperature: 2 hours</P>
<P>Target temperature: 33°C</P>
<P>Duration of cooling: 12 hours after target temperature was reached</P>
<P>Rewarming: passive after 12 hours, active after 18 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Survival with good neurological function to be sent home or to a rehabilitation facility at discharge</P>
<P>In-hospital death</P>
<P>Haemodynamic, biochemical and haematological effects of hypothermia</P>
<P>For IPD analysis, best ever reached CPC during hospital stay and CPC discharge provided</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-02 16:41:19 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: odd and even days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-HACA-2002">
<CHAR_METHODS MODIFIED="2012-01-01 10:50:58 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: in hospital</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 275, mean age 59 years, 24% female</P>
<P>In-hospital and out-of-hospital bystander-witnessed cardiac arrest of presumed cardiac cause, ventricular fibrillation or non-perfusing ventricular tachycardia as first cardiac rhythm, comatose after resuscitation</P>
<P>Participating sites: European university and community hospitals</P>
<P>Multi-centre: yes</P>
<P>Language: English</P>
<P>Allocation concealment: opaque envelopes</P>
<P>Outcome assessor blind: yes</P>
<P>Intention-to-treat analysis: yes</P>
<P>Groups comparable: significantly more diabetes and coronary heart disease and bystander CPR in control group</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Therapeutic hypothermia vs standard intensive care treatment</P>
<P>Means of cooling: cooling blanket that covered the whole body and released cooled air</P>
<P>Cooling rate: time from ROSC to target temperature: median of 8 hours</P>
<P>Target temperature: 32°C to 34°C</P>
<P>Duration of cooling: median 24 hours</P>
<P>Rewarming: passive over 8 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Best CPC of 1, 2 vs CPC of 3, 4, 5 during 6 months</P>
<P>Mortality at 6 months, rate of complication during first 7 days after cardiac arrest (bleeding of any severity)</P>
<P>Pneumonia, sepsis, pancreatitis, renal failure, pulmonary oedema, seizures, arrhythmias and pressure sores</P>
<P>For IPD analysis, best ever reached CPC during hospital stay and CPC discharge provided</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: computer-generated random sequence</P>
<P>Centre-specific subsets of this study are also published as <LINK REF="REF-Tiainen-2003" TYPE="REFERENCE">Tiainen 2003</LINK> (n = 70), <LINK REF="REF-Tiainen-2005" TYPE="REFERENCE">Tiainen 2005</LINK> (n = 60) and <LINK REF="REF-Tiainen-2007" TYPE="REFERENCE">Tiainen 2007</LINK> (n = 70) with more detailed investigations of neuropsychological and laboratory outcomes</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<CHAR_METHODS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: in-hospital</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 33, mean age 72 years, 39% female</P>
<P>Out-of-hospital cardiac arrest of cardiac cause, pulseless electrical activity or asystole as first cardiac rhythm, comatose after resuscitation</P>
<P>Participating site: Belgian university hospital</P>
<P>Multi-centre: no</P>
<P>Language: English</P>
<P>Outcome assessor blind: yes</P>
<P>Intention-to-treat analysis: yes</P>
<P>Groups comparable: yes, although groups were small, no significant differences</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Therapeutic hypothermia vs standard post-resuscitation care protocol</P>
<P>Means of cooling: helmet device placed around head and neck and containing a solution of aqueous glycerol</P>
<P>Cooling rate: starting point until target temperature not clearly stated</P>
<P>Target temperature: 34°C</P>
<P>Duration of cooling: start of cooling to start of rewarming, 4 hours</P>
<P>Rewarming: passive over 8 hours</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Haemodynamic data, arterial pH, electrolytes, haematological data</P>
<P>Complications such as pneumonia, sepsis, cardiac arrhythmia, coagulopathy</P>
<P>Survival to hospital discharge and overall performance categories (OPCs)<BR/>
</P>
<P>For IPD analysis, best ever reached CPC during hospital stay and CPC discharge provided</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: random number tables</P>
<P>IPD included 33 participants; article reported on only 30, as follow-up was not completed at the time of submission</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Laurent-2005">
<CHAR_METHODS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: pre-hospital</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 42, mean age 52 years in HF group, 56 years in HF+HT group, 19% female</P>
<P>Out-of-hospital cardiac arrest of presumed cardiac cause, ventricular fibrillation or asystole as first cardiac rhythm, comatose after resuscitation</P>
<P>Participating sites: French university and community hospital</P>
<P>Multi-centre: yes</P>
<P>Language: English</P>
<P>Allocation concealment: opaque envelopes</P>
<P>Outcome assessor blind: not stated</P>
<P>Intention-to-treat analysis: yes</P>
<P>Groups comparable: yes</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>High-flow haemofiltration vs high-flow haemofiltration + therapeutic hypothermia vs standard supportive care</P>
<P>Means of cooling: direct external cooling of blood</P>
<P>Cooling rate: 4 hours after ICU admission, median temperature 31.7°C</P>
<P>Target temperature: 32°C to 33°C</P>
<P>Duration of cooling: 24 hours</P>
<P>Rewarming: passive</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Survival at 6 months</P>
<P>Rate of death by intractable shock in participants who had a favourable Glasgow Coma Scale (M5 or M6) or who required sedation</P>
<P>Survival at CPC 1, 2 vs all else at 6 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization pre-hospital to save time for haemofiltration</P>
<P>We did not pool data from this study with data from the other 3 studies, as treatment schemes with haemofiltration are not comparable with treatment schemes with non-haemofiltration treatment (clinical heterogeneity)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Mori-2000">
<CHAR_METHODS MODIFIED="2012-01-01 10:50:26 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 54, mean age unknown, gender distribution unknown</P>
<P>Out-of-hospital cardiac arrest of unknown cause with Glasgow Coma Scale score &lt; 8</P>
<P>Participating site: Japanese university hospital</P>
<P>Multi-centre: unknown</P>
<P>Language of abstract: English</P>
<P>Allocation concealment: unknown</P>
<P>Outcome assessor blind: not stated</P>
<P>Intention-to-treat analysis: unknown</P>
<P>Groups comparable: unknown</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>"Brain-hypothermic treatment" vs "brain normothermic treatment"</P>
<P>Means of cooling: water-circulating blankets above and below participant with another ice mounted blanket over participant</P>
<P>Cooling rate: unknown</P>
<P>Target temperature: 32°C to 34°C</P>
<P>Duration of cooling: 3 days</P>
<P>Rewarming: unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Glasgow outcome scale at 1 month (5-point scale). Categories "moderate, mild, or no disabilities" defined as "good neurological outcome"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Only abstract published</P>
<P>Study now included in the pooled analysis, as we received information on the cooling method, whether cooling was applied locally or systemically</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Nielsen-2013">
<CHAR_METHODS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Randomization: <BR/>performed centrally with the use of a computer-generated assignment sequence</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Total number of participants 950, mean age 64 years, 19% female</P>
<P>Age &#8805; 18 years, out-of-hospital cardiac arrest of presumed cardiac cause, sustained return of spontaneous circulation comatose after resuscitation (GCS &lt; 8)</P>
<P>Participating sites: 36 intensive care units (ICUs) in Europe and Australia, university and community</P>
<P>Multi-centre: yes</P>
<P>Language: English</P>
<P>Allocation concealment: centrally</P>
<P>Outcome assessor blind: yes</P>
<P>Intention-to-treat analysis: modified intention-to-treat analysis</P>
<P>Groups comparable: higher incidence of previous AMI and ischaemic heart disease in 33°C group</P>
<P>Follow-up &gt; 80% of randomly assigned participants: yes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Group 1: target temperature 33°C</P>
<P>Group 2: target temperature 36°C</P>
<P>Means of temperature control: ice cold fluids, ice packs and intravascular or surface temperature-management devices at the discretion of sites<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>All-cause mortality through the end of the trial</P>
<P>CPC of 3 to 5 around 180 days</P>
<P>Modified Rankin scale around 180 days</P>
<P>Mortality at 180 days</P>
<P>Individual neurological scores<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Control group differs (36°) from control group of other studies (no cooling)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AMI = acute myocardial infarction</P>
<P>CPC = cerebral performance category</P>
<P>CPR = cardiopulmonary resuscitation<BR/>
</P>
<P>GCS = Glasgow Coma Scale<BR/>HF = haemofiltration</P>
<P>HT = hypothermia<BR/>ICU = intensive care unit</P>
<P>IPD = individual patient data<BR/>M5 = localizes painful stimuli<BR/>M6 = obeys commands</P>
<P>OPC = overall performance category</P>
<P>ROSC = restoration of spontaneous circulation</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-CAEP_x002f_ACMU-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Substudy to <LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>; no outcome information on additional patients available</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Lopez_x002d_de_x002d_Sa-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Intervention and control groups did not meet inclusion criteria; control group of 34°C and lower</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" STUDY_ID="STD-Takeda-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<P>Intervention and control groups did not meet inclusion criteria, relevant numbers of participants in control and intervention groups not continuously cooled</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-11-11 13:56:16 +0000" MODIFIED_BY="Jasmin " SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-11-23 20:22:32 +0000" MODIFIED_BY="Jasmin " SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-10 22:47:34 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Odd and even days</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Treatment assignments randomly generated by computer in blocks of 10, with stratification according to centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>Random sequence generated with random number tables</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>Computer-generated 1/1/1 randomization sequence prepared for each centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-11-04 12:06:37 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Randomization performed centrally with the use of a computer-generated assignment sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-10 22:47:36 +0100" MODIFIED_BY="Jane Cracknell" RESULT="NO" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Odd and even days</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Sealed envelopes containing treatment assignments provided by biostatistics centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>After stabilization and insertion of catheters, participants prospectively blindly randomly assigned to 2 groups (treatment allocation concealed by use of opaque envelopes)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>Participants randomly allocated to treatment by use of sealed opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-11-04 12:07:01 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Randomization performed centrally</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1" REF_IDS="CMP-001.01">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-11-13 13:23:25 +0000" MODIFIED_BY="Jasmin " RESULT="YES" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Treating personnel not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Personnel involved in care of patients during first 48 hours after cardiac arrest could not be blinded to treatment assignments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>Treating personnel not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>Blinding to assigned treatment not feasible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Treating personnel not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-11-13 13:24:58 +0000" MODIFIED_BY="Jasmin " NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Complete follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Two participants lost to follow-up, properly addressed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>Differences between published report and IPD properly reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-04-15 07:59:49 +0100" MODIFIED_BY="Jasmin " RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>No loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-11-04 12:07:04 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>11 out of 950 participants excluded after randomization (for various reasons)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-04-15 08:10:50 +0100" MODIFIED_BY="Jasmin " NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-10 22:47:42 +0100" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>No other major biases seen</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-14 13:23:21 +0100" MODIFIED_BY="Jasmin " RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>No other major biases seen</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-15 08:34:27 +0100" MODIFIED_BY="Jasmin " RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>No other major biases seen</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-04-15 08:00:23 +0100" MODIFIED_BY="Jasmin " RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>No other major biases seen</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-11-04 12:07:05 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Time from collapse to resuscitation 1 minute - considerably shorter than in other trials</P>
<P>Period between return of spontaneous circulation and start of therapy not defined, slow cooling rate</P>
<P>Dose-finding study with pragmatic study design - risk of non-effect in both groups and misleading interpretation of equivalence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="9">
<NAME>Funding</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-24 09:35:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Supported by grants of the Fourth RTD Framework Programme 1994&#8211;1998 of the European Union, the Austrian Ministry of Science and Transport and the Austrian Science Foundation<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-24 09:39:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="UNKNOWN" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>For this study, haemofiltration circuits, catheters and replacement fluid concentrates provided by GAMBRO AB, with estimated cost of &#8364;120 per participant treated by haemofiltration</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-24 09:47:27 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information provided</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-24 09:46:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Funded by the Swedish Heart&#8211;Lung Foundation and others</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="GROUP" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="10">
<NAME>Blinding of outcome assessment (detection bias) Good neurologic outcome</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-10.01" NO="1" REF_IDS="CMP-001.01 CMP-001.02">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2015-11-04 12:08:19 +0000" MODIFIED_BY="Harald Herkner" RESULT="YES" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Outcome assessment blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Personnel involved in care of patients during first 48 hours after cardiac arrest could not be blinded to treatment assignments. However, physicians responsible for assessing neurological outcome within first 6 months after the arrest unaware of treatment assignments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>Outcome assessors blind to the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2015-11-04 12:14:38 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>Outcome assessor blind: not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2015-11-04 12:16:00 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION>
<P>No information available from abstract and correspondence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-10.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Outcome assessment blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="11">
<NAME>Blinding of outcome assessment (detection bias) Survivial</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-11.01" NO="1" REF_IDS="CMP-002.01 CMP-002.02">
<NAME>Survival</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2015-11-04 12:08:49 +0000" MODIFIED_BY="Harald Herkner" RESULT="YES" STUDY_ID="STD-Bernard-2002">
<DESCRIPTION>
<P>Outcome assessment blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-HACA-2002">
<DESCRIPTION>
<P>Assessors of survival within first 6 months after arrest were unaware of treatment assignments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001">
<DESCRIPTION>
<P>Outcome assessors blind to the intervention</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Laurent-2005">
<DESCRIPTION>
<P>Outcome assessor blind: not stated, but for survival, risk of bias regarded as low</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2015-11-04 12:16:37 +0000" MODIFIED_BY="Harald Herkner" RESULT="UNKNOWN" STUDY_ID="STD-Mori-2000">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-11.01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" RESULT="YES" STUDY_ID="STD-Nielsen-2013">
<DESCRIPTION>
<P>Outcome assessment blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">Neurological outcome, survival and adverse events: conventional cooling compared with no cooling and 36°C for neuroprotection and survival in adults after cardiopulmonary resuscitation</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Neurological outcome, survival and adverse events: conventional cooling compared with no cooling and 36</B>°<B>C </B>
<B>for neuroprotection and survival in adults after cardiopulmonary resuscitation</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> adults after cardiopulmonary resuscitation<BR/>
<B>Settings: </B>emergency medicine and intensive care, worldwide<BR/>
<B>Intervention:</B> conventional cooling 32°C to 34°C<BR/>
<B>Comparison: </B>no cooling (good neurological outcome and survival); no cooling and 36°C (adverse events)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Number of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>No cooling</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cooling 32°C to 34°C</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Good neurological outcome</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.94 (1.18 to 3.21)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>437<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>a,,b</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>325 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>631 per 1000<BR/>(384 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>Survival</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>RR 1.35<BR/>(1.10 to 1.65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>383<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>b,c</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="2" VALIGN="TOP">
<P/>
<P/>
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>420 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>567 per 1000<BR/>(462 to 693)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Adverse events - pneumonia</P>
</TD>
<TD COLSPAN="2">
<P>Study population</P>
</TD>
<TD ROWSPAN="2">
<P>RR 1.15<BR/>(1.02 to 1.30)</P>
</TD>
<TD ROWSPAN="2">
<P>1205<BR/>(2 RCTs)</P>
</TD>
<TD ROWSPAN="2">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE<SUP>d</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>423 per 1000</P>
</TD>
<TD>
<P>486 per 1000<BR/>(431 to 549)</P>
</TD>
</TR>
<TR>
<TD ROWSPAN="2">
<P>Adverse events - hypokalaemia</P>
</TD>
<TD COLSPAN="2">
<P>Study population</P>
</TD>
<TD ROWSPAN="2">
<P>RR 1.38<BR/>(1.03 to 1.84)</P>
</TD>
<TD ROWSPAN="2">
<P>975<BR/>(2 RCTs)</P>
</TD>
<TD ROWSPAN="2">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW<SUP>e,f</SUP>
</P>
</TD>
<TD ROWSPAN="2">
<P/>
</TD>
</TR>
<TR>
<TD>
<P>134 per 1000</P>
</TD>
<TD>
<P>185 per 1000<BR/>(138 to 247)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (with its 95% confidence interval) is based on assumed risk in the comparison group and <B>relative effect</B> of the intervention (and its 95% CI)<BR/>
<B>CI: </B>Confidence interval</P>
<P/>
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>One quasi-randomized trial (<LINK REF="STD-Bernard-2002" TYPE="STUDY">Bernard 2002</LINK>) and one abstract (<LINK REF="STD-Mori-2000" TYPE="STUDY">Mori 2000</LINK>) but both not contributing to most data (see also <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK> - <B>'Sensitivity analysis')</B>
</P>
<P>
<SUP>b</SUP>Total number of events &lt; 300; imprecision therefore was rated as serious, and this resulted in downgrading of the overall quality of the evidence one level from high to moderate</P>
<P>
<SUP>c</SUP>One quasi-randomized trial not contributing to the majority of data (see also <LINK TAG="INTERVENTION_EFFECTS" TYPE="SECTION">Effects of interventions</LINK> - <B>'Sensitivity analysis')</B>
</P>
<P>
<SUP>d</SUP>Indirectness was caused mostly by control group treatment (<LINK REF="STD-Nielsen-2013" TYPE="STUDY">Nielsen 2013</LINK>), which resulted in downgrading of the overall quality of the evidence one level from high to moderate</P>
<P>
<SUP>e</SUP>Indirectness was rated as very serious because of differences in intervention (haemofiltration, conventional cooling) and control group treatments (no cooling, 36°C), which resulted in downgrading of the overall quality of the evidence two levels from high to low</P>
<P>
<SUP>f</SUP>
<LINK REF="STD-Laurent-2005" TYPE="STUDY">Laurent 2005</LINK> had some risk of bias but is not contributing to the majority of data</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<TITLE MODIFIED="2012-07-22 11:30:04 +0100" MODIFIED_BY="[Empty name]">Subgroup analyses</TITLE>
<TABLE COLS="4" ROWS="13">
<TR>
<TH>
<P>Outcome or subgroup</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>Participants</P>
</TH>
<TH>
<P>Risk ratio (M-H, fixed, 95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Good neurological outcome by cardiac cause vs non-cardiac cause</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>383</P>
</TD>
<TD>
<P>1.54 (1.22 to 1.95)</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiac cause</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>372</P>
</TD>
<TD>
<P>1.51 (1.19 to 1.91)</P>
</TD>
</TR>
<TR>
<TD>
<P>Non-cardiac cause</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>3.80 (0.55 to 26.29)</P>
</TD>
</TR>
<TR>
<TD>
<P>Good neurological outcome by location of cardiac arrest</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>382</P>
</TD>
<TD>
<P>1.56 (1.23 to 1.98)</P>
</TD>
</TR>
<TR>
<TD>
<P>In-hospital</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD>
<P>1.64 (0.47 to 5.73)</P>
</TD>
</TR>
<TR>
<TD>
<P>Out-of-hospital</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>365</P>
</TD>
<TD>
<P>1.56 (1.23 to 1.99)</P>
</TD>
</TR>
<TR>
<TD>
<P>Good neurological outcome by witnessed cardiac arrest</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>382</P>
</TD>
<TD>
<P>1.49 (1.18 to 1.88)</P>
</TD>
</TR>
<TR>
<TD>
<P>Witnessed cardiac arrest</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>360</P>
</TD>
<TD>
<P>1.43 (1.13 to 1.81)</P>
</TD>
</TR>
<TR>
<TD>
<P>Non-witnessed cardiac arrest</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>5.31 (1.40 to 20.21)</P>
</TD>
</TR>
<TR>
<TD>
<P>Good neurological outcome by primary ECG rhythm</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>382</P>
</TD>
<TD>
<P>1.51 (1.19 to 1.91)</P>
</TD>
</TR>
<TR>
<TD>
<P>VF/VT rhythm</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>330</P>
</TD>
<TD>
<P>1.47 (1.15 to 1.88)</P>
</TD>
</TR>
<TR>
<TD>
<P>Non- VF/VT rhythm</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>52</P>
</TD>
<TD>
<P>2.17 (0.68 to 6.93)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>ECG = electrocardiogram</P>
<P>VF/VT = ventricular fibrillation/ventricular tachycardia</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<TITLE MODIFIED="2012-07-22 11:32:27 +0100" MODIFIED_BY="[Empty name]">Sensitivity analysis</TITLE>
<TABLE COLS="4" ROWS="5">
<TR>
<TH>
<P>Outcome or subgroup</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>Participants</P>
</TH>
<TH>
<P>Risk ratio</P>
<P>(M-H, Fixed, 95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>Good neurological outcome for all studies with conventional cooling</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>437</P>
</TD>
<TD>
<P>1.94 (1.18 to 3.21)</P>
</TD>
</TR>
<TR>
<TD>
<P>Studies with conventional cooling and adequate or unknown allocation concealment</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>360</P>
</TD>
<TD>
<P>2.46 (0.96 to 6.28)</P>
</TD>
</TR>
<TR>
<TD>
<P>Studies with conventional cooling and adequate allocation concealment</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>445</P>
</TD>
<TD>
<P>1.97 (0.71 to 5.45)</P>
</TD>
</TR>
<TR>
<TD>
<P>Studies with other cooling methods and adequate allocation concealment</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>42</P>
</TD>
<TD>
<P>0.71 (0.32 to 1.54)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="3">
<TITLE MODIFIED="2015-03-07 19:56:58 +0000" MODIFIED_BY="[Empty name]">Adverse effects</TITLE>
<TABLE COLS="4" ROWS="20">
<TR>
<TH>
<P>Outcome or subgroup</P>
</TH>
<TH>
<P>Studies</P>
</TH>
<TH>
<P>Participants</P>
</TH>
<TH>
<P>Risk ratio</P>
<P>(M-H, Fixed, 95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P/>
<P>Bleeding of any severity</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>1206</P>
</TD>
<TD>
<P/>
<P>1.14 (0.96 to 1.35)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Need for platelet transfusion</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>273</P>
</TD>
<TD>
<P/>
<P>5.11 (0.25 to 105.47)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Significant haemorrhagic complications</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>77</P>
</TD>
<TD>
<P/>
<P>Not estimable</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Pneumonia</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>1205</P>
</TD>
<TD>
<P/>
<P>1.15 (1.02 to 1.30)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Pancreatitis</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>273</P>
</TD>
<TD>
<P/>
<P>0.51 (0.05 to 5.57)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Sepsis</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>1206</P>
</TD>
<TD>
<P/>
<P>1.14 (0.81 to 1.61)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Septic shock</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>933</P>
</TD>
<TD>
<P/>
<P>0.87 (0.50 to 1.52)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Renal failure or oliguria</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>303</P>
</TD>
<TD>
<P/>
<P>0.88 (0.48 to 1.61)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Haemodialysis</P>
</TD>
<TD>
<P/>
<P>3</P>
</TD>
<TD>
<P/>
<P>1288</P>
</TD>
<TD>
<P/>
<P>1.16 (0.80 to 1.67)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Seizures</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>1202</P>
</TD>
<TD>
<P/>
<P>1.18 (0.98 to 1.42)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Lethal or long-lasting arrhythmia</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>315</P>
</TD>
<TD>
<P/>
<P>1.21 (0.88 to 1.67)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Any arrhythmia</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>933</P>
</TD>
<TD>
<P/>
<P>0.98 (0.93 to 1.04)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Pulmonary oedema</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P>269</P>
</TD>
<TD>
<P/>
<P>1.76 (0.61 to 5.12)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Cardiac complications</P>
</TD>
<TD>
<P/>
<P>1</P>
</TD>
<TD>
<P/>
<P/>
</TD>
<TD>
<P/>
<P>No totals</P>
</TD>
</TR>
<TR>
<TD>
<P/>
<P>Hypokalaemia</P>
</TD>
<TD>
<P/>
<P>2</P>
</TD>
<TD>
<P/>
<P>975</P>
</TD>
<TD>
<P/>
<P>1.38 (1.03 to 1.84)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypophosphataemia</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>975</P>
</TD>
<TD>
<P>1.10 (0.92 to 1.33)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypoglycaemia</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>933</P>
</TD>
<TD>
<P>1.12 (0.64 to 1.97)</P>
</TD>
</TR>
<TR>
<TD>
<P>Hypomagnesaemia</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>933</P>
</TD>
<TD>
<P>1.20 (0.88 to 1.65)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pressure sores</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>269</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<COMPARISON ID="CMP-001" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1">
<NAME>Neurological outcome: therapeutic hypothermia versus no hypothermia</NAME>
<DICH_OUTCOME CHI2="18.419134207202845" CI_END="1.147694256443489" CI_START="0.8861434353304384" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0084749531415476" ESTIMABLE="YES" EVENTS_1="347" EVENTS_2="298" I2="72.85431582313603" I2_Q="73.86947370786405" ID="CMP-001.01" LOG_CI_END="0.059826208249730124" LOG_CI_START="-0.05249597548234557" LOG_EFFECT_SIZE="0.003665116383692281" METHOD="MH" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.002464492744291169" P_Q="0.0217761385641444" P_Z="0.8982211716318252" Q="7.653883345632826" RANDOM="YES" SCALE="8.83" SORT_BY="USER" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.1096195477165544" TOTALS="SUB" TOTAL_1="722" TOTAL_2="690" WEIGHT="300.0" Z="0.1279087687311968">
<NAME>All studies with subgroups</NAME>
<GROUP_LABEL_1>cooling to 33°C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cooling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.703300466297006" CI_END="3.209722601755149" CI_START="1.1767679273901077" DF="3" EFFECT_SIZE="1.943475910209486" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="67" I2="47.39887863653418" ID="CMP-001.01.01" LOG_CI_END="0.5064675004008972" LOG_CI_START="0.07069082325846893" LOG_EFFECT_SIZE="0.288579161829683" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.12697234449907213" P_Z="0.009435810459950926" STUDIES="4" TAU2="0.11677151769934266" TOTAL_1="231" TOTAL_2="206" WEIGHT="100.00000000000001" Z="2.5958468800296703">
<NAME>Conventional cooling vs no cooling</NAME>
<DICH_DATA CI_END="17.30393303197168" CI_START="1.170254182247759" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="2" LOG_CI_END="1.2381448256692782" LOG_CI_START="0.0682802018814093" LOG_EFFECT_SIZE="0.6532125137753437" MODIFIED="2015-11-11 12:36:33 +0000" MODIFIED_BY="Jasmin " ORDER="12" O_E="0.0" SE="0.6871842709362768" STUDY_ID="STD-Mori-2000" TOTAL_1="36" TOTAL_2="18" VAR="0.4722222222222222" WEIGHT="11.124807148087639"/>
<DICH_DATA CI_END="17.08000890911872" CI_START="1.0575228675880104" EFFECT_SIZE="4.25" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2324880928857784" LOG_CI_START="0.024289767214844545" LOG_EFFECT_SIZE="0.6283889300503115" MODIFIED="2015-11-11 12:36:31 +0000" MODIFIED_BY="Jasmin " ORDER="20" O_E="0.0" SE="0.7097016771772737" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001" TOTAL_1="16" TOTAL_2="17" VAR="0.5036764705882353" WEIGHT="10.560823617371835"/>
<DICH_DATA CI_END="1.8091810571849192" CI_START="1.0819726748771774" EFFECT_SIZE="1.3991013071895424" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="54" LOG_CI_END="0.25748203186896734" LOG_CI_START="0.03421629284087427" LOG_EFFECT_SIZE="0.14584916235492076" MODIFIED="2015-11-11 12:36:28 +0000" MODIFIED_BY="Jasmin " ORDER="55" O_E="0.0" SE="0.13114740028833421" STUDY_ID="STD-HACA-2002" TOTAL_1="136" TOTAL_2="137" VAR="0.017199640602388565" WEIGHT="48.90934624377002"/>
<DICH_DATA CI_END="3.493012863727839" CI_START="0.9744830926885806" EFFECT_SIZE="1.8449612403100775" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" LOG_CI_END="0.5432001850180447" LOG_CI_START="-0.011225691503518707" LOG_EFFECT_SIZE="0.265987246757263" MODIFIED="2015-11-11 12:36:30 +0000" MODIFIED_BY="Jasmin " ORDER="56" O_E="0.0" SE="0.32567250432111705" STUDY_ID="STD-Bernard-2002" TOTAL_1="43" TOTAL_2="34" VAR="0.106062580070788" WEIGHT="29.405022990770515"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1128791069129391" CI_START="0.8481044166957701" DF="0" EFFECT_SIZE="0.971513090916076" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="222" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.04644798908561293" LOG_CI_START="-0.0715506750980853" LOG_EFFECT_SIZE="-0.012551343006236209" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="1.0" P_Z="0.6767099139757601" STUDIES="1" TAU2="0.0" TOTAL_1="469" TOTAL_2="464" WEIGHT="100.0" Z="0.416956927775632">
<NAME>Conventional cooling vs 36° temperature management</NAME>
<DICH_DATA CI_END="1.1128791069129391" CI_START="0.8481044166957701" EFFECT_SIZE="0.971513090916076" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="222" LOG_CI_END="0.04644798908561293" LOG_CI_START="-0.0715506750980853" LOG_EFFECT_SIZE="-0.012551343006236209" MODIFIED="2015-11-11 12:36:24 +0000" MODIFIED_BY="Jasmin " ORDER="31" O_E="0.0" SE="0.06931299944431235" STUDY_ID="STD-Nielsen-2013" TOTAL_1="469" TOTAL_2="464" VAR="0.0048042918919672445" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5429731045130268" CI_START="0.32401665546546066" DF="0" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.18835835596374348" LOG_CI_START="-0.4894326651303297" LOG_EFFECT_SIZE="-0.1505371545832931" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="3" P_CHI2="1.0" P_Z="0.38396459570532504" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="100.0" Z="0.8706146648037183">
<NAME>Cooling with haemofiltration vs no cooling</NAME>
<DICH_DATA CI_END="1.5429731045130268" CI_START="0.32401665546546066" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.18835835596374348" LOG_CI_START="-0.4894326651303297" LOG_EFFECT_SIZE="-0.1505371545832931" MODIFIED="2015-11-11 12:36:22 +0000" MODIFIED_BY="Jasmin " ORDER="54" O_E="0.0" SE="0.39813780091032364" STUDY_ID="STD-Laurent-2005" TOTAL_1="22" TOTAL_2="20" VAR="0.1585137085137085" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="17.276005463122033" CI_END="2.2906970903964665" CI_START="1.017145594946126" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.5264247295077062" ESTIMABLE="YES" EVENTS_1="340" EVENTS_2="289" I2="76.84649956531595" I2_Q="85.37177044356612" ID="CMP-001.02" LOG_CI_END="0.359967664192971" LOG_CI_START="0.0073831225943360975" LOG_EFFECT_SIZE="0.18367539339365355" METHOD="MH" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.0017082480082147855" P_Q="0.008933438814980765" P_Z="0.04114683949190531" Q="6.836097260725399" RANDOM="YES" SCALE="8.83" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.11794791119825439" TOTALS="YES" TOTAL_1="700" TOTAL_2="670" WEIGHT="100.0" Z="2.0420473017083682">
<NAME>Conventional cooling</NAME>
<GROUP_LABEL_1>cooling to 33°C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cooling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.703300466297006" CI_END="3.209722601755149" CI_START="1.1767679273901077" DF="3" EFFECT_SIZE="1.943475910209486" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="67" I2="47.39887863653418" ID="CMP-001.02.01" LOG_CI_END="0.5064675004008972" LOG_CI_START="0.07069082325846893" LOG_EFFECT_SIZE="0.288579161829683" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.12697234449907213" P_Z="0.009435810459950926" STUDIES="4" TAU2="0.11677151769934266" TOTAL_1="231" TOTAL_2="206" WEIGHT="65.05601391035347" Z="2.5958468800296703">
<NAME>Conventional cooling vs no cooling</NAME>
<DICH_DATA CI_END="17.30393303197168" CI_START="1.170254182247759" EFFECT_SIZE="4.5" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="2" LOG_CI_END="1.2381448256692782" LOG_CI_START="0.0682802018814093" LOG_EFFECT_SIZE="0.6532125137753437" MODIFIED="2015-11-13 13:32:24 +0000" MODIFIED_BY="Jasmin " ORDER="12" O_E="0.0" SE="0.6871842709362768" STUDY_ID="STD-Mori-2000" TOTAL_1="36" TOTAL_2="18" VAR="0.4722222222222222" WEIGHT="7.268160542787207"/>
<DICH_DATA CI_END="17.08000890911872" CI_START="1.0575228675880104" EFFECT_SIZE="4.25" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.2324880928857784" LOG_CI_START="0.024289767214844545" LOG_EFFECT_SIZE="0.6283889300503115" MODIFIED="2015-11-13 13:32:23 +0000" MODIFIED_BY="Jasmin " ORDER="20" O_E="0.0" SE="0.7097016771772737" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001" TOTAL_1="16" TOTAL_2="17" VAR="0.5036764705882353" WEIGHT="6.900390980370964"/>
<DICH_DATA CI_END="1.8091810571849192" CI_START="1.0819726748771774" EFFECT_SIZE="1.3991013071895424" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="54" LOG_CI_END="0.25748203186896734" LOG_CI_START="0.03421629284087427" LOG_EFFECT_SIZE="0.14584916235492076" MODIFIED="2015-11-11 12:35:51 +0000" MODIFIED_BY="Jasmin " ORDER="55" O_E="0.0" SE="0.13114740028833421" STUDY_ID="STD-HACA-2002" TOTAL_1="136" TOTAL_2="137" VAR="0.017199640602388565" WEIGHT="31.739023164737514"/>
<DICH_DATA CI_END="3.493012863727839" CI_START="0.9744830926885806" EFFECT_SIZE="1.8449612403100775" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="9" LOG_CI_END="0.5432001850180447" LOG_CI_START="-0.011225691503518707" LOG_EFFECT_SIZE="0.265987246757263" MODIFIED="2015-11-13 13:32:23 +0000" MODIFIED_BY="Jasmin " ORDER="56" O_E="0.0" SE="0.32567250432111705" STUDY_ID="STD-Bernard-2002" TOTAL_1="43" TOTAL_2="34" VAR="0.106062580070788" WEIGHT="19.148439222457792"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1128791069129391" CI_START="0.8481044166957701" DF="0" EFFECT_SIZE="0.971513090916076" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="222" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.04644798908561293" LOG_CI_START="-0.0715506750980853" LOG_EFFECT_SIZE="-0.012551343006236209" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="1.0" P_Z="0.6767099139757601" STUDIES="1" TAU2="0.0" TOTAL_1="469" TOTAL_2="464" WEIGHT="34.94398608964652" Z="0.416956927775632">
<NAME>Conventional cooling vs 36° temperature management</NAME>
<DICH_DATA CI_END="1.1128791069129391" CI_START="0.8481044166957701" EFFECT_SIZE="0.971513090916076" ESTIMABLE="YES" EVENTS_1="218" EVENTS_2="222" LOG_CI_END="0.04644798908561293" LOG_CI_START="-0.0715506750980853" LOG_EFFECT_SIZE="-0.012551343006236209" MODIFIED="2015-11-11 12:35:23 +0000" MODIFIED_BY="Jasmin " ORDER="31" O_E="0.0" SE="0.06931299944431235" STUDY_ID="STD-Nielsen-2013" TOTAL_1="469" TOTAL_2="464" VAR="0.0048042918919672445" WEIGHT="34.94398608964652"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<NAME>Survival: therapeutic hypothermia versus no hypothermia</NAME>
<DICH_OUTCOME CHI2="8.884559214650562" CI_END="1.1735014080603632" CI_START="0.950427148910988" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.056090714619649" ESTIMABLE="YES" EVENTS_1="355" EVENTS_2="329" I2="54.97807034248773" I2_Q="75.80718323296367" ID="CMP-002.01" LOG_CI_END="0.06948361503599958" LOG_CI_START="-0.022081166582335734" LOG_EFFECT_SIZE="0.023701224226831914" METHOD="MH" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.06405067362363948" P_Q="0.016027372320938427" P_Z="0.31026809557210766" Q="8.266916660672104" RANDOM="NO" SCALE="8.83" SORT_BY="USER" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="690" TOTAL_2="674" WEIGHT="300.0" Z="1.0146596770738474">
<NAME>All studies with subgroups</NAME>
<GROUP_LABEL_1>cooling to 33°C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cooling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5587037122267544" CI_END="1.6532149519751345" CI_START="1.1016736908118032" DF="2" EFFECT_SIZE="1.34955674865776" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="79" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.218329324465302" LOG_CI_START="0.042052978122645225" LOG_EFFECT_SIZE="0.13019115129397363" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.4587033659892056" P_Z="0.0037902210980770377" STUDIES="3" TAU2="0.0" TOTAL_1="195" TOTAL_2="188" WEIGHT="99.99999999999999" Z="2.895112962529625">
<NAME>Conventional cooling vs no cooling</NAME>
<DICH_DATA CI_END="34.09561459963029" CI_START="0.5297602114553422" EFFECT_SIZE="4.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5326985233426789" LOG_CI_START="-0.27592066324205594" LOG_EFFECT_SIZE="0.6283889300503115" MODIFIED="2015-10-28 12:35:22 +0000" MODIFIED_BY="Jasmin " ORDER="20" O_E="0.0" SE="1.062391863009236" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001" TOTAL_1="16" TOTAL_2="17" VAR="1.1286764705882353" WEIGHT="1.2119698672326964"/>
<DICH_DATA CI_END="1.5845912244955023" CI_START="1.030704844076758" EFFECT_SIZE="1.2779850746268657" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="67" LOG_CI_END="0.19991724646389067" LOG_CI_START="0.013134317135420563" LOG_EFFECT_SIZE="0.10652578179965558" MODIFIED="2015-10-28 12:35:39 +0000" MODIFIED_BY="Jasmin " ORDER="55" O_E="0.0" SE="0.10971721727795511" STUDY_ID="STD-HACA-2002" TOTAL_1="136" TOTAL_2="137" VAR="0.01203786776721801" WEIGHT="83.43280476131018"/>
<DICH_DATA CI_END="2.6807475272647987" CI_START="0.8499986344587893" EFFECT_SIZE="1.5095137420718816" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.4282559140653611" LOG_CI_START="-0.07058177198863548" LOG_EFFECT_SIZE="0.17883707103836283" MODIFIED="2015-10-28 12:42:48 +0000" MODIFIED_BY="Jasmin " ORDER="56" O_E="0.0" SE="0.29301972607448773" STUDY_ID="STD-Bernard-2002" TOTAL_1="43" TOTAL_2="34" VAR="0.08586055986876781" WEIGHT="15.35522537145711"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1028796757060333" CI_START="0.8583042192198004" DF="0" EFFECT_SIZE="0.972936934724062" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="241" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.04252813344891017" LOG_CI_START="-0.06635875258124589" LOG_EFFECT_SIZE="-0.011915309566167853" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="1.0" P_Z="0.6679587746935722" STUDIES="1" TAU2="0.0" TOTAL_1="473" TOTAL_2="466" WEIGHT="100.0" Z="0.42895115226027897">
<NAME>Conventional cooling vs 36° temperature management</NAME>
<DICH_DATA CI_END="1.1028796757060333" CI_START="0.8583042192198004" EFFECT_SIZE="0.972936934724062" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="241" LOG_CI_END="0.04252813344891017" LOG_CI_START="-0.06635875258124589" LOG_EFFECT_SIZE="-0.011915309566167853" MODIFIED="2015-10-28 12:37:19 +0000" MODIFIED_BY="Jasmin " ORDER="31" O_E="0.0" SE="0.06396069585289241" STUDY_ID="STD-Nielsen-2013" TOTAL_1="473" TOTAL_2="466" VAR="0.004090970613986208" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5429731045130268" CI_START="0.32401665546546066" DF="0" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="0.18835835596374348" LOG_CI_START="-0.4894326651303297" LOG_EFFECT_SIZE="-0.1505371545832931" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="3" P_CHI2="1.0" P_Z="0.38396459570532504" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="20" WEIGHT="100.0" Z="0.8706146648037183">
<NAME>Cooling with haemofiltration vs no cooling</NAME>
<DICH_DATA CI_END="1.5429731045130268" CI_START="0.32401665546546066" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.18835835596374348" LOG_CI_START="-0.4894326651303297" LOG_EFFECT_SIZE="-0.1505371545832931" MODIFIED="2015-10-28 12:32:09 +0000" MODIFIED_BY="Jasmin " ORDER="54" O_E="0.0" SE="0.39813780091032364" STUDY_ID="STD-Laurent-2005" TOTAL_1="22" TOTAL_2="20" VAR="0.1585137085137085" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.877642631273226" CI_END="1.185957542626999" CI_START="0.9586882436421625" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0662849307644053" ESTIMABLE="YES" EVENTS_1="348" EVENTS_2="320" I2="61.91754132016111" I2_Q="86.16516207039884" ID="CMP-002.02" LOG_CI_END="0.07406914153004367" LOG_CI_START="-0.018322598332940757" LOG_EFFECT_SIZE="0.02787327159855143" METHOD="MH" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="0.048609410588989155" P_Q="0.007177019843428556" P_Z="0.23697311792808096" Q="7.228129487952935" RANDOM="NO" SCALE="8.83" SORT_BY="USER" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="668" TOTAL_2="654" WEIGHT="100.0" Z="1.18258642050643">
<NAME>Conventional cooling</NAME>
<GROUP_LABEL_1>cooling to 33°C</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cooling</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5587037122267544" CI_END="1.6532149519751345" CI_START="1.1016736908118032" DF="2" EFFECT_SIZE="1.34955674865776" ESTIMABLE="YES" EVENTS_1="110" EVENTS_2="79" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.218329324465302" LOG_CI_START="0.042052978122645225" LOG_EFFECT_SIZE="0.13019115129397363" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="1" P_CHI2="0.4587033659892056" P_Z="0.0037902210980770377" STUDIES="3" TAU2="0.0" TOTAL_1="195" TOTAL_2="188" WEIGHT="24.785736858968544" Z="2.895112962529625">
<NAME>Conventional cooling vs no cooling</NAME>
<DICH_DATA CI_END="34.09561459963029" CI_START="0.5297602114553422" EFFECT_SIZE="4.25" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5326985233426789" LOG_CI_START="-0.27592066324205594" LOG_EFFECT_SIZE="0.6283889300503115" MODIFIED="2015-10-28 12:39:48 +0000" MODIFIED_BY="Jasmin " ORDER="20" O_E="0.0" SE="1.062391863009236" STUDY_ID="STD-Hachimi_x002d_Idrissi-2001" TOTAL_1="16" TOTAL_2="17" VAR="1.1286764705882353" WEIGHT="0.30039566210228663"/>
<DICH_DATA CI_END="1.5845912244955023" CI_START="1.030704844076758" EFFECT_SIZE="1.2779850746268657" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="67" LOG_CI_END="0.19991724646389067" LOG_CI_START="0.013134317135420563" LOG_EFFECT_SIZE="0.10652578179965558" MODIFIED="2015-10-28 12:39:48 +0000" MODIFIED_BY="Jasmin " ORDER="55" O_E="0.0" SE="0.10971721727795511" STUDY_ID="STD-HACA-2002" TOTAL_1="136" TOTAL_2="137" VAR="0.01203786776721801" WEIGHT="20.679435442195324"/>
<DICH_DATA CI_END="2.6807475272647987" CI_START="0.8499986344587893" EFFECT_SIZE="1.5095137420718816" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.4282559140653611" LOG_CI_START="-0.07058177198863548" LOG_EFFECT_SIZE="0.17883707103836283" MODIFIED="2015-10-28 12:46:04 +0000" MODIFIED_BY="Jasmin " ORDER="56" O_E="0.0" SE="0.29301972607448773" STUDY_ID="STD-Bernard-2002" TOTAL_1="43" TOTAL_2="34" VAR="0.08586055986876781" WEIGHT="3.805905754670935"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1028796757060333" CI_START="0.8583042192198004" DF="0" EFFECT_SIZE="0.972936934724062" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="241" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="0.04252813344891017" LOG_CI_START="-0.06635875258124589" LOG_EFFECT_SIZE="-0.011915309566167853" MODIFIED="2015-12-01 10:13:46 +0000" MODIFIED_BY="Jane Cracknell" NO="2" P_CHI2="1.0" P_Z="0.6679587746935722" STUDIES="1" TAU2="0.0" TOTAL_1="473" TOTAL_2="466" WEIGHT="75.21426314103145" Z="0.42895115226027897">
<NAME>Conventional cooling vs 36° temperature management</NAME>
<DICH_DATA CI_END="1.1028796757060333" CI_START="0.8583042192198004" EFFECT_SIZE="0.972936934724062" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="241" LOG_CI_END="0.04252813344891017" LOG_CI_START="-0.06635875258124589" LOG_EFFECT_SIZE="-0.011915309566167853" MODIFIED="2015-10-28 12:40:28 +0000" MODIFIED_BY="Jasmin " ORDER="31" O_E="0.0" SE="0.06396069585289241" STUDY_ID="STD-Nielsen-2013" TOTAL_1="473" TOTAL_2="466" VAR="0.004090970613986208" WEIGHT="75.21426314103145"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-11-23 19:40:11 +0000" MODIFIED_BY="Jasmin " NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtAAAAG/CAYAAABxHeCOAABEgklEQVR42u29f0Rf/////yaZJBnJ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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsEAAAEZCAMAAABB6giZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAXwAAAJsCAIAAABxu4+bAAAefklEQVR42u3dMW8Ux//H8ZOQEIUL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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Neurological outcome: therapeutic hypothermia versus no hypothermia, outcome: 1.1 All studies with subgroups.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2kAAAJwCAMAAAAk+NlzAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="5" REF_ID="CMP-001.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Neurological outcome: therapeutic hypothermia versus no hypothermia, outcome: 1.2 Conventional cooling.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA2cAAAIgCAMAAAA2v+E3AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="6" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Survival: therapeutic hypothermia versus no hypothermia, outcome: 3.1 All studies with subgroups.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1gAAAJgCAMAAACgHzLuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2016-02-03 15:12:57 +0000" MODIFIED_BY="Jane Cracknell" NO="7" REF_ID="CMP-002.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_MORE_DECIMALS:NO;SHOW_WEIGHT_COLUMN:YES;SHOW_ROB_TABLE:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Survival: therapeutic hypothermia versus no hypothermia, outcome: 3.2 Conventional cooling.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1YAAAIQCAMAAAC19A+cAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2009-07-20 10:29:13 +0100" MODIFIED_BY="Jane Cracknell"/>
<APPENDICES MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<APPENDIX ID="APP-01" MODIFIED="2012-07-22 12:06:37 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-07-22 12:06:37 +0100" MODIFIED_BY="[Empty name]">Search strategy: CENTRAL, The Cochrane Library</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-11 09:05:18 +0000" MODIFIED_BY="[Empty name]">
<P>#1 MeSH descriptor Resuscitation explode all trees<BR/>#2 MeSH descriptor Cardiopulmonary Resuscitation explode all trees<BR/>#3 MeSH descriptor Resuscitation Orders explode all trees<BR/>#4 MeSH descriptor Heart Arrest explode all trees<BR/>#5 MeSH descriptor Heart Massage explode all trees<BR/>#6 ((cardio?pulmonary or order*) near2 resuscitation):ti,ab<BR/>#7 reanimation:ti,ab<BR/>#8 ((circulatory or circulation or cardiac) near arrest):ti,ab or heart standstill:ti,ab<BR/>#9 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8)<BR/>#10 MeSH descriptor Cryotherapy explode all trees<BR/>#11 MeSH descriptor Hypothermia explode all trees<BR/>#12 MeSH descriptor Hypothermia, Induced explode all trees<BR/>#13 ((resuscitative or therapeutic or artificial or induced or extracorporeal) near hypothermia)<BR/>#14 artificial hibernation or body cooling or refrigeration anesthesia or body temperature:ti,ab or refrigeration:ti,ab<BR/>#15 (#10 OR #11 OR #12 OR #13 OR #14)<BR/>#16 (#9 AND #15)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-01-11 17:56:38 +0000" MODIFIED_BY="Jane Cracknell" NO="2">
<TITLE MODIFIED="2012-01-11 17:56:38 +0000" MODIFIED_BY="[Empty name]">Search strategy: MEDLINE (Ovid SP)</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-11 09:05:18 +0000" MODIFIED_BY="Karen Hovhannisyan">
<P>1. Resuscitation/ or Cardiopulmonary Resuscitation/ or Resuscitation Orders/ or Heart Arrest/ or Heart Massage/ or advanced cardiac life support.mp. or ((cardio?pulmonary or order*) adj2 resuscitation).ti,ab. or reanimation.ti,ab. or ((circulatory or circulation or cardiac) adj3 arrest).ti,ab. or heart standstill.ti,ab. <BR/>2. Cryotherapy/ or Hypothermia/ or Circulatory Arrest, Deep Hypothermia Induced/ or Hypothermia, Induced/ or ((resuscitative or therapeutic or artificial or induced or extracorporeal) adj3 hypothermia).mp. or artificial hibernation.mp. or body cooling.mp. or chilling.mp. or refrigeration anesthesia.mp. or body temperature.ti,ab. or refrigeration.ti,ab. <BR/>3. 1 and 2<BR/>4. ((randomised controlled trial or controlled clinical trial).pt. or randomised.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh. <BR/>5. 3 and 4</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-01-11 17:56:38 +0000" MODIFIED_BY="Jane Cracknell" NO="3">
<TITLE MODIFIED="2012-01-11 17:56:38 +0000" MODIFIED_BY="[Empty name]">Search strategy: EMBASE (Ovid SP)</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-11 09:05:18 +0000" MODIFIED_BY="[Empty name]">
<P>1. resuscitation/ or heart arrest/ or heart massage/ or advanced cardiac life support.mp. or ((cardio?pulmonary or order*) adj2 resuscitation).ti,ab. or reanimation.ti,ab. or ((circulatory or circulation or cardiac) adj3 arrest).ti,ab. or heart standstill.ti,ab.<BR/>2. cryotherapy/ or hypothermia/ or ((resuscitative or therapeutic or artificial or induced or extracorporeal) adj3 hypothermia).mp. or artificial hibernation.mp. or body cooling.mp. or chilling.mp. or refrigeration anesthesia.mp. or body temperature.ti,ab. or refrigeration.ti,ab.<BR/>3. 1 and 2<BR/>4. (placebo.sh. or controlled study.ab. or random*.ti,ab. or trial*.ti,ab. or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)).ti,ab.) not (animals not (humans and animals)).sh.<BR/>5. 3 and 4</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="4">
<TITLE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">Search strategy: CINAHL (EBSCO Host)</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-11 09:05:18 +0000" MODIFIED_BY="[Empty name]">
<P>S1 ( (MH "Resuscitation") OR (MH "Resuscitation Orders") OR (MH "Resuscitation, Cardiopulmonary") OR (MH "Heart Arrest") OR (MH "Heart Massage") ) OR AB ( ((cardio?pulmonary or order*) and resuscitation) ) OR AB reanimation OR ( (circulatory or circulation or cardiac) and arrest ) OR heart standstill <BR/>S2  ( (MH "Cryotherapy") OR (MH "Hypothermia") OR (MH "Hypothermia, Induced") ) OR ( ((resuscitative or therapeutic or artificial or induced or extracorporeal) and hypothermia) ) OR artificial hibernation OR body cooling OR refrigeration anesthesia <BR/>S3 ( (MH "randomised Controlled Trials") OR (MH "Random Assignment") OR (MH "Prospective Studies") OR (MH "Multicenter Studies") OR (MH "Clinical Trials") OR (MH "Clinical Trial Registry") OR (MH "Double-Blind Studies") OR (MH "Single-Blind Studies") OR (MH "Triple-Blind Studies") OR (MH "Placebos") ) OR ( random* or controlled clinical trial or placebo ) <BR/>S4 S1 and S2 and S3</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="5">
<TITLE MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">Search strategy: BIOSIS (Ovid SP)</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-11 09:05:17 +0000" MODIFIED_BY="[Empty name]">
<P>1. advanced cardiac life support.mp. or ((cardio?pulmonary or order*) adj2 resuscitation).ti,ab. or reanimation.ti,ab. or ((circulatory or circulation or cardiac) adj3 arrest).ti,ab. or heart standstill.ti,ab.<BR/>2. (((resuscitative or therapeutic or artificial or induced or extracorporeal) adj3 hypothermia) or artificial hibernation or body cooling or chilling or refrigeration anesthesia).mp. or body temperature.ti,ab. or refrigeration.ti,ab.<BR/>3. 1 and 2</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell" NO="6">
<TITLE MODIFIED="2015-03-07 19:56:15 +0000" MODIFIED_BY="[Empty name]">Data extraction form</TITLE>
<APPENDIX_BODY MODIFIED="2016-02-03 15:12:52 +0000" MODIFIED_BY="Jane Cracknell">
<TABLE COLS="2" ROWS="30">
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Data extraction sheet</P>
<P>Hypothermia for neuroprotection after cardiopulmonary resuscitation</P>
<P>Update review</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Reviewer:</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Date:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Decision:</P>
</TD>
<TD VALIGN="TOP">
<UL>
<LI>inclusion</LI>
<LI>exclusion</LI>
</UL>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>Reasons for exclusion:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Study characteristics</P>
</TD>
<TD VALIGN="TOP">
<P>Publication type:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Language</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Setting</P>
</TD>
<TD VALIGN="TOP">
<P>Multi-centre:</P>
<UL>
<LI>yes</LI>
<LI>no</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Participating sites:</P>
<UL>
<LI>university</LI>
<LI>community hospitals</LI>
<LI>other, please specify</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Participants</P>
</TD>
<TD VALIGN="TOP">
<P>Total number of patients:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Mean age:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Percentage female:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Cardiac arrest</P>
<UL>
<LI>out-of-hospital</LI>
<LI>in-hospital</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Cause of cardiac arrest</P>
<UL>
<LI>cardiac</LI>
<LI>non-cardiac</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Primary cardiac rhythm</P>
<UL>
<LI>any</LI>
<LI>ventricular fibrillation</LI>
<LI>ventricular tachycardia</LI>
<LI>asystole</LI>
<LI>pulseless electrical activity</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Quality</P>
</TD>
<TD VALIGN="TOP">
<P>Allocation concealment</P>
<UL>
<LI>adequate</LI>
<LI>unclear</LI>
</UL>
<UL>
<UL>
<LI>inadequate</LI>
</UL>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Outcome assessor blind</P>
<UL>
<LI>yes</LI>
<LI>no</LI>
<LI>if unclear, please explain</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Intention-to-treat:</P>
<UL>
<LI>yes</LI>
<LI>no</LI>
<LI>if unclear, please explain</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Groups comparable:</P>
<UL>
<LI>yes</LI>
<LI>if not, please specify</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Follow-up &gt; 80% of randomly assigned participants:</P>
<UL>
<LI>yes</LI>
<LI>if not, please specify</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Intervention</P>
</TD>
<TD VALIGN="TOP">
<P>Type of intervention:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Controls:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Time from restoration of spontaneous circulation to target temperature:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Cooling rate:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Duration of cooling:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Rewarming:</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Outcomes</P>
</TD>
<TD VALIGN="TOP">
<P>Types of outcome measures:</P>
<UL>
<LI>..</LI>
<LI>..</LI>
<LI>..</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P>Time point of assessment of outcome measures:</P>
<UL>
<LI>..</LI>
<LI>..</LI>
<LI>..</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Funding</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Notes</P>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
</TABLE>
<P/>
<P>
<B>Risk of bias assessment</B>
</P>
<P/>
<TABLE COLS="2" ROWS="10">
<TR>
<TD VALIGN="TOP">
<P>Allocation concealment</P>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Inclusion/exclusion explicitly reported:</P>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Intention-to-treat:</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Appropriate participant description</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Identical care</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Outcomes appropriately defined:</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Follow-up &gt; 80%:</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Physician blinded:</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Outcome assessor blinded</P>
<P>(outcomes other than mortality):</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P>rating</P>
<UL>
<LI>low risk</LI>
<LI>unclear risk</LI>
<LI>high risk</LI>
</UL>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
<P>Other risks of bias</P>
<P/>
</TD>
<TD VALIGN="TOP">
<P>Short description:</P>
<P/>
</TD>
</TR>
</TABLE>
<P/>
<P>Results primary:</P>
<TABLE COLS="4" ROWS="4">
<TR>
<TD COLSPAN="4" VALIGN="TOP">
<P>
<B>Type of outcome:</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Cooling</B>
</P>
</TD>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>No cooling</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Events (n)</P>
</TD>
<TD VALIGN="TOP">
<P>Total (N)</P>
</TD>
<TD VALIGN="TOP">
<P>Events (n)</P>
</TD>
<TD VALIGN="TOP">
<P>Total (N)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
</TABLE>
<P/>
<P>Results secondary:</P>
<TABLE COLS="4" ROWS="4">
<TR>
<TD COLSPAN="4" VALIGN="TOP">
<P>
<B>Type of outcome:</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>Cooling</B>
</P>
</TD>
<TD COLSPAN="2" VALIGN="TOP">
<P>
<B>No cooling</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Events (n)</P>
</TD>
<TD VALIGN="TOP">
<P>Total (N)</P>
</TD>
<TD VALIGN="TOP">
<P>Events (n)</P>
</TD>
<TD VALIGN="TOP">
<P>Total (N)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
<TD VALIGN="TOP">
<P/>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;6 studies remained&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 additional record identified through other sources&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;8 studies remained&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;2455 of records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2455 of records identified through database searching (duplicates removed)&lt;/p&gt;" WIDTH="163"/>
<OUT TEXT="&lt;p&gt;2447 of records excluded according to inclusion criteria&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3 further studies excluded after discussing eligibility criteria/further information from study authors&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>